Journal Pre-proof
Medicinal plants used by traditional medicine practitioners to boost the
immune system in people living with HIV/AIDS in Uganda
G. Anywar, E. Kakudidi, R. Byamukama, J. Mukonzo, A. Schubert,
H. Oryem-Origa
PII:
S1876-3820(19)30986-2
DOI:
https://doi.org/10.1016/j.eujim.2019.101011
Reference:
EUJIM 101011
To appear in:
European Journal of Integrative Medicine
Received Date:
8 October 2019
Revised Date:
15 November 2019
Accepted Date:
15 November 2019
Please cite this article as: { doi: https://doi.org/
This is a PDF file of an article that has undergone enhancements after acceptance, such as
the addition of a cover page and metadata, and formatting for readability, but it is not yet the
definitive version of record. This version will undergo additional copyediting, typesetting and
review before it is published in its final form, but we are providing this version to give early
visibility of the article. Please note that, during the production process, errors may be
discovered which could affect the content, and all legal disclaimers that apply to the journal
pertain.
© 2019 Published by Elsevier.
Medicinal plants used by traditional medicine practitioners to boost the immune system
in people living with HIV/AIDS in Uganda
Anywar G*1, 4, Kakudidi E1, Byamukama R2, Mukonzo J3, Schubert, A4, Oryem-Origa H1,
1
Department of Plant Sciences, Microbiology & Biotechnology, College of Natural Sciences, Makerere
University, P.O. Box 7062, Kampala, Uganda
2
Department of Chemistry, College of Natural Sciences, Makerere University, P.O. Box 7062, Kampala,
Uganda
3
Department of Pharmacology & Therapeutics, College of Health Sciences, Makerere University, P.O.
Box 7062, Kampala, Uganda
4
Fraunhofer Institute for Cell Therapy & Immunology (IZI), Perlickstraße 104103, Leipzig, Germany
Corresponding author: godwinanywar@gmail.com / ganywar@cartafrica.org /ganywar@cns.mak.ac.ug
of
Abstract
ur
na
lP
re
-p
ro
Introduction: People living with HIV/AIDS (PLHIV) widely use medicinal plants for
boosting immunity and managing infections. The aim of this study was to document the
medicinal plant species used by herbalists to boost the immune system of people living with
HIV/AIDS in Uganda. Materials and Methods: Semi-structured questionnaires were
administered to 90 herbalists to obtain ethnobotanical information on medicinal plant species
used from different parts of Uganda. A detailed literature review of the pharmacology,
phytochemistry, toxicology and other traditional used of the documented medicinal plants was
also conducted. Results: Seventy-one medicinal plant species from 37 families and 64 genera
were identified. Trees contributed 38.0% of the species used and herbs 35.2%. The majority of
the herbal medicines were made from leaves (35.6%), bark (24.1%) and roots (20.7%).
Zanthoxylum chalybeum Engl. and Psidium guajava L. were the most widely used species with
citation frequencies (CF) of 11 each. These were followed by Warburgia ugandensis Sprague,
Acacia hockii De Wild. and Bridelia micrantha (Hochst.) Baill (CF = 8 each), Mangifera indica
L., Markhamia lutea (Benth.) K. Schum., Aloe vera (L.) Burm.f. and Erythrina abyssinica DC.
(CF = 7 each). Most traditional medicine practitioners (TMP) (85.6%) used herbs for boosting
immunity for PLHIV, whether or not the patients were on antiretroviral treatment. The patients
often disclosed their sero-status to the TMP who considered all PLHIV to be
immunocompromised. Conclusion: Herbalists widely prescribe medicinal plant species for
boosting or restoring the immunity in PLHIV in Uganda.
Key words: Medicinal plants, Ethnobotanical survey, immunomodulation, herbalists,
HIV/AIDS, Uganda.
Jo
1.0 Introduction
A healthy immune system is involved defending the body from attacks but when compromised,
it can lead to the development of several chronic illnesses which conventional medicine has
not adequately addressed [1,2]. AIDS is the commonest immunosuppressive disease in the
world [3]. It is caused by HIV, which attacks and destroys the body’s immune system,
particularly CD4 cells (T cells), and leads to a state of immunodeficiency and susceptibility to
infections [3,4]. The concept of modulating our immune responses as a cure to various illnesses
1
has stimulated a lot of interest [5,6]. Modulation of the immune system is highly desirable in
counteracting conditions of compromised immunity [7], such as AIDS. Immunomodulators are
biomolecules of synthetic or biological origin capable of regulating, suppressing and
stimulating parts of the immune system [8,9]. Natural immunomodulators are often used to
restore compromised immunity by activating the host’s defensive mechanism [10]. Regrettably,
most immunostimulants and immunosuppressants in clinical use are either cytotoxic [8,11] or
even cause fatalities [12]. Conversely, natural products are generally reconsidered to be safer,
more accessible and easy to prepare and apply [13,14].
Several plant species have been frequently used in traditional medicine to treat disorders of the
of
immune system [6,15], and thus represent a source for potential immunomodulating adjuvants
[16]. Different studies have demonstrated novel and significant immunomodulatory activities
ro
in various plant species [6,17,18]. Immunomodulatory agents can also be used as immune
-p
stimulators to reduce the side effects of drug-induced immunosuppression [6,7,19,20].
One of the most important uses of herbal medicines in HIV infection is in boosting the immune
re
system [21]. This has created a demand for traditional medicine that boost immunity or
improve health and wellbeing [22], especially by many PLHIV [23–26]. Thus an
ur
na
lP
ethnobotanical study was conducted to documented medicinal plant species specifically used
for boosting immunity in immunocompromised people living with HIV/AIDS in Uganda
2.0 Methods
2.1 Study area
A survey was carried out in the districts of Arua in the Northwest, Dokolo in the North, Mbale
and Iganga in the East, Bushenyi in the West, Rakai in the South, Luwero (Figure 1), as part
Jo
of a larger study conducted by Anywar et al. [23].
Figure 1: Map of Uganda showing study sites. Adopted from Anywar et al. [23].
2.2 Study design
Ninety herbalists were interviewed in an ethnobotanical study carried out in 2017, in the
respective districts. Different languages were spoken in the different districts surveyed (Table
1).
2
Table 1: Languages spoken & Number of TMP interviewed by districts
Only herbalists who belonged to local association and had been administering herbs for
boosting immunity in PLHIV for a minimum of 5 years were included in the study. Semistructured interviews were conducted with regard the criteria the TMP used for assessing ones
immune status, the medicinal plant species they used to restore immune function and the
methods of preparation.
2.3 Collection of plant specimens
Plant voucher specimens were collected from the field with the assistance of the herbalists
of
following standard guidelines described in Martin [27]. The specimens were taken to the
Makerere University Herbarium for identification. Classification of the plant species was done
ro
using theplantlist database at http://www.theplantlist.org accessed on 4thJanuary-March, 2018
at 18:09 EAT. Plant family names were verified using the Angiosperm Phylogeny Group IV.
-p
2.4 Ethical considerations
The Higher Degrees Research and Ethics Committee of the School of Biomedical Sciences,
re
College of Health Sciences, Makerere University and the Uganda National Council of Science
and Technology (UNCST) cleared this study, (Ethical clearance No. HS 2233). All the
ur
na
lP
herbalists were required to consent in writing prior to participating in the study.
2.5 Data analysis
The data obtained was analysed and presented using descriptive statistics. In addition, an
extensive literature review was conducted to ascertain the pharmacological, biological and
clinical evidence supporting the use of the documented plant species as immunomodulators.
In addition, an extensive review of published literature on the immonomodulatory or
Jo
immmunostimulatory properties of the documented medicinal plant species was conducted.
We also searched for other known therapeutic or pharmacological properties and
ethnomedicinal uses of the documented plant from various databases and publishers such as
Google scholar, web of science and PubMed. The results of the review were analysed to give
a comparison on the use of these plant species in our study vis-à-vis what is done elsewhere.
Results
3.1 Socio-Demographic characteristics of the traditional medicine practitioners’
3
The average age of the herbalists was 51.1 years. The majority of the herbalists were men
(66.7%) with primary level education (34.4%). About one third of the TMP (30.0%) had no
education whereas 5.5% had obtained tertiary level education. Most TMP were Christians
(74.5%), Muslims (24.4) and animists (1.1%). The TMP were predominantly subsistence
farmers (73.3 %). While the rest were full-time TMP (3.3%), traditional birth attendants (3.3%)
and businesses owners (7.8%) run various. The rest did various jobs to supplement their
incomes.
3.2 Medicinal plant species used
Seventy-one medicinal plant species from 37 families and 64 genera were documented (Table
of
2). With the exception of two species Amaranthus and Aloe, the rest were identified to species
level. Fabaceae had 11 species, Asteraceae (5) and Pyllanthaceae (4). Acanthaceae,
ro
Anacardiaceae, Apocynaceae, Bignoniaceae and Rubiaceae had 3 species each. The plant
species used were trees (38.0%) and herbs (35.2%), while shrubs contributed (19.7%), climbers
-p
(5.6%) and scramblers (1.4%). Leaves were the most frequently used plant parts (35.6%),
re
followed by bark (24.1%) and roots (20.7%).
The medicinal species used with the highest frequency of mention were; Psidium guajava L.
and Zanthoxylum chalybeum Engl. (11 each), Warburgia ugandensis Sprague, Acacia hockii
ur
na
lP
De Wild. and Bridelia micrantha (Hochst.) Baill (8 each), Mangifera indica L., Markhamia
lutea (Benth.) K. Schum., Aloe vera and Erythrina abyssinica DC. (7 each).
Table 2: Medicinal plants used by TMP to boost the immune system in immunocompromised patients living with HIV/AIDS
3.3 Preparation and administration of traditional herbal medicines by TMP
Decoctions (boiling) single plant species was the most commonly used method of preparation
used (43.8%). This was followed by teas/infusions (20.0%), decoctions with other herbs
Jo
(18.8%). A peculiar method of preparation was the use of clay “tablets” locally called
“mumbwa” in the Luganda language (Plate 1). The TMP make clay tablets by crushing
particular herbs and mixing them with wet clay. The tablets are then moulded and dried (3.8%).
The use of clay tablets was only recorded in central and eastern Uganda. Although most of the
medicines were prepared with water, occasionally honey and milk were used. Honey served as
a medicine, excipient and a sweetener to improve palatability.
3.4 Diagnosis and treatment of PLHIV with herbal
4
The herbalists used one’s HIV sero-status as a proxy for immunosuppression even if the
patients were asymptomatic. Most of the TMP (77%) relied on laboratory tests from modern
health facilities for confirmatory diagnosis of the patients’ sero-status. The majority of the
herbalists (85.6%), reported that some of their patients were taking both ARV and herbal
medicines. The patients often disclosed their sero-status to the TMP. Patients took herbal
preparations mainly to improve their general wellbeing and quality of life. Improvement in the
immune system was inferred from reduced frequency of illness, improved appetite, strength
and vitality, as well as remission of some of the opportunistic infections. The herbalists also
claimed that there was a reduction in severity of the ARV side effects experienced by patients
of
such as nausea and fatigue experienced by the patients when they used herbal medicines.
Table 3 presents a cross-reference of the medicinal plant species and any known
ro
immunostimulatory or other relevant pharmacological effects and other ethnomedicinal
uses in relation to HIV/AIDS.
-p
Table 3: Cross reference of medicinal plants species used to boost the immune system in PLHIV in
Uganda
re
4.0 Discussion
4.1 Medicinal plant species used and knowledge of TMP
ur
na
lP
The use of medicinal plants species to boost immunity and stimulate appetite in PLHIV has
previously been reported [6,15,371]. Most of the plant species in this study are widely used in
different parts of Uganda for treating various diseases [371,372]. They have several
pharmacological activities that have been reviewed in table 3. The most frequently used plant
species have the following pharmacological, phytochemical and toxicological profiles
properties:
P. guajava contains meroterpenoids with antitumor activity [278]. It also has antibacterial
Jo
[279], antiinflamatory [280] and immunomodulatory properties [281]. Z. chalybeum has
skimmianine with in vitro antiviral activity against measles virus [341]. W. ugandensis is
immunostimulatory [145], antimicrobial [146] and anti-inflammatory [147]. It contains several
phytochemicals such as ugandensolide, ugandensidial, muzigadial, polygodial, waburganal
and cinnamolide [148,149] A. hockii has antipyretic properties [206] with no available reports
on other pharmacological properties and toxicology. However, other Acacia spp have been
shown to have anti-HIV activity. They include A. catechu which suppresses HIV-1 infection
5
in vitro [373], A. auriculiformis [374] and A. mellifera [375] with in vitro anti-HIV activity.
M. indica has antimicrobial [64], anti-inflammatory and immunomodulatory properties. M.
indica extracts are administered as nutritional supplement in AIDS and cancer [65] and contain
several phytochemicals such as protocatechic acid, catechin, mangiferin and γ–aminobutyric
acid [63]. M. lutea has been shown to have antiviral properties with various phenylpropanoid
glycosides such as luteoside A, B & C [137]. B. micrantha has antiviral-against HIV-1 reverse
transcriptase [289]. It also has antidiarrhoeal, antiinflammatory, antimalarial, antinociceptive
properties [290] and is rich in phenolics [291], alkaloids, flavonoids, steroids, tannins &
saponins [292]. A. vera has antiinflamatory properties and stimulates immunity [353,354]. E.
abyssinica has anticancer properties due to the presence of compounds such as pterocarpans
of
[217] and antimicrobial properties due to the presence of compounds alkaloids such as tannins
ro
alkaloids and flavones [88].
The TMP considered remission of opportunistic and improvement of general wellbeing of
-p
patients to be as a result of an improved immune system. However, there is a possibility that
the herbs may have a direct antiviral effect on HIV. The in vitro antiviral activity of medicinal
re
plants has been demonstrated in different studies [289,376]. Ten of the plant species
documented have proven antiviral activity against a range of viruses including hepatitis B,
ur
na
lP
measles and even HIV-1. The plant species with antiviral activity are: A. sativum [44], L.
barteri [59], S. pyroides [68,69], E. angustifolia antiviral [117], M. lutea [137], P. granatum
[260], B. micrantha (anti-HIV-1 RT [289], R. cordifolia (hepatitis B) [325], and Z. chalybeum
(measles) [341]. There is also a likelihood that the reported concurrent use of ARV and herbal
medicines by patients leads to a reduction the viral load causing a rebound of the immune
system.
All these plant species have no reported cases of toxicity and are considered safe from animal
Jo
studies (Table 3) with the exception of A. vera where cases of toxicity have been reported in
both mice and humans in the form of acute hepatitis [355,356,358], B. micrantha with mild
toxicity reported in brine shrimp assays [72,293] and Z. chalybeum which is associated with
impaired kidney function and neoplasms in experimental animals at high doses [342,343].
4.2 Methods of preparation of medicinal plant extracts by TMP
Medicinal plant products were prepared by boiling them either singly or in combination with
6
other herbs. The practice is common for TMP preparing HIV medications [23,70,79]. The
consumption of clay of geophagy apparently is ancient and widely practiced in many parts of
the world for religious and medicinal purposes and part of routine diet [377]. Abrahams [378]
and Anywar et al. [23] have reported the ingestion of clay for therapeutic purposes in Uganda.
In some instances, the moulded clay tablets were smoked. Abrahams [378]made similar
findings in his study but also observed that the moulded “tablets” were marked in various
distinct ways as a way of labelling them to distinguish them from others.
Many soils eaten in Uganda and other parts of Africa are typical tropical red soils, which are
normally rich in silica but widely, varying in elemental composition [379]. However, the kinds
of
of soils observed in this study were typically greyish clay soils. Such soils are high clay content
are generally richer in magnesium. In addition, some of the clays are similar in composition to
ro
kaolin or china clay, which is a natural form of the hydrated aluminium silicate used in certain
commercial diarrhoea medications [379]. In fact, clay can is used as a traditional antidiarrheal
-p
agent to treat acute gastroenteritis [380]. Clay serves as a preservative and binding agent for
the herbal medicine [23,378], an adsorbent or detoxifier of herbal medicines [381] or to give
re
the medicine a distinctive smell desired by the consumer [378]. Red soils have the ability to
ur
na
lP
prevent iron deficiency in anaemia [382,383].
However, despite the widespread belief in the benefits of geophagy, especially among pregnant
women in Africa, they could have limited bioavailability [382]. According to Minnich et al.
[384], soils have the ability to enhance or inhibit the absorption of different elements iron
absorption such as iron or potassium depending on their cation exchange capacity. This can
affect the recommended dietary allowance of certain minerals in the body. Geophagy has also
been associated with some nutritional disorders as well as the risk of ingesting contaminants
[385], which may be radioactive substances [386] and exposure to soil-borne or geohelminth
Jo
infection [387].
4.3 Treatment of PLHIV with herbal medicines
The TMP prescribed herbal remedies in immunocompromised PLHIV to stimulate appetite,
boost immunity and helping in regaining strength and recuperating. The patients sought ways
to neutralize the side effects of the ARV by taking herbs. This is common practice in many
African countries [23,388]. Patients also trusted herbal medicines and considered them
effective, more readily available and affordable. Langlois-Klassen et al. [389] reported that
7
PLHIV used herbal medicines because of their familiarity with them and the desire to quickly
relieve the symptoms they suffer. Generally, there is increasing use of herbal remedies in
PLHIV [23,25], who report improvement in their conditions after treatment [24]. This could
partly explain why PLHIV commonly look for an alternative traditional medicine parallel to
conventional therapy [24]. It is also widely acknowledged that TMP provide healthcare to a
substantial proportion of PLHIV in high HIV burden countries in sub-Saharan Africa [390].
4.4 Properties and mode of action of medicinal plant species used as immune
immunomodulators
Of the 71 plant species, one third (22, 31.0%) have direct references in the literature pertaining
of
to their in vitro or in vivo immunomodulatory properties. Additionally, 17 species (23.9%) have
antimicrobial or antimycobacterial properties, 11 (16.2%) have anticancer or antiproliferative
ro
properties, 17 (23.9%) with antimalarial or antiplasmodium activities and 16 (22.5%) have
antiviral or anti-HIV activity. Other ethnobotanical studies cited point to the fact that most of
-p
the medicinal plants are used in treating various HIV/AIDS opportunistic infections [23,70,79].
Although some of the therapeutic or pharmacologic activities of the medicinal plants
re
mentioned do not play a direct role as immunomodulators, they may be beneficial in promoting
health of PLHIV. For instance, plants with antimicrobial or antimycobacterial properties are
ur
na
lP
useful in PLHIV because they are frequently afflicted by opportunistic infections caused by
such pathogens or cancers [3]. The plasmodium parasite impairs the immune system’s ability
to trigger an efficient immune response [391].
Different mechanisms by which medicinal plant species exert their immunostimulatory effects
have been studied. Some medicinal plant extracts may have significant immunostimulatory
effect on both the cell-mediated and humoral immune systems in vivo [272] Others medicinal
plant species may exert their immunostimulatory effects via different mediators such as the
Jo
induction of IFN-α and β [392], or the production of IFN-γ & IL-4 [145]. Medicinal plant
extracts may also activate the immune system by; (i) triggering the alternating complement
pathway and raising the number and distribution of white blood cells, and (ii) stimulating
phagocytosis, T-cell production, lymphocytic activity, cytokine production, cellular respiration
& enzyme secretion [116].
4.5 Toxicity and safety of used medicinal plant species
We did not find any literature on the toxicity of 15 of the plant species documented. Forty8
three of the species documented were reported to be safe or non-toxic in various studies where
they were evaluated for acute and sub-acute oral toxicities mainly in animal models. The
remaining 13 plant species: A. boonei, S. hadiensis, K. africana, J. curcas, M. esculenta, P.
edulis, B. micrantha, H. acida, S. longipedunculata, C. articulata, Z. chalybeum, U. massaica
and A. vera were reported to have varying degrees and types of toxicity, depending on the dose
administered, plant part used, extraction solvent and duration of exposure as reported in table
3. For instance, although P. edulis leaves were reported to be toxic in the review [287,288],
the locals in this study were using the fruits and roots as medicine. Although the roots of M.
esculenta is reported to be toxic [204], the locals were using the leaves as medicine. Besides,
they have over the years selected less-toxic varieties but also devised means to detoxify the
of
roots through prolonged boiling for example. The levels of toxicity reported also vary with
dosage. It is not surprising therefore that herbalists try to regulate the doses of the medicinal
ro
plants they administer.
-p
1.2 Potential herb-drug interactions with concurrent use of herbal medicines and ARVs
Orthodox medical doctors are concerned about the potential of herb-drug interactions, which
re
are likely to increase with the increasing availability of ARVs and use of herbs [70]. Some
medicinal plant species have been shown to have undesirable or even harmful effects when
ur
na
lP
combined with ARV. A case in point is the ARV, Indinavir, which is a protease inhibitor that
is a substrate for both P-gp and CYP3A4. Pharmacokinetic interactions between indinavir and
herbs such as garlic decrease its bioavailability [393]. This will have the obvious effect of
making the drug less effective because the correct dose will not be achieved. However, the
specific pharmacokinetic and pharmacodynamic interactions between various herbal
medicines or combinations of herbal medicines and ARVs have mostly not been investigated.
It is therefore important to be mindful of such potential herb-interactions when using herbs or
Jo
ARV.
4.8 Conclusion
Herbalists widely prescribe medicinal plant species for boosting or restoring the immunity in
PLHIV in Uganda. There is scientific evidence to support the use of many of the plant species
as immunostimulants, from pharmacological and clinical studies. In addition, these plant
species also have other pharmacologically important properties that support the immune
function such as; anti-HIV, antimicrobial and anticancer activities and creation of awareness
about the possible dangers of geophagy and polypharmacy. We therefore recommend further
9
studies to scientifically validate the immunostimulatory effects of the medicinal plant species
used by the TMP.
All research done by the authors with financial support from the Consortium for Advanced
Research Training in Africa (CARTA) and DAAD:
Funding
Source
All sources of funding should also be acknowledged and you should declare any involvement of study
sponsors in the study design; collection, analysis and interpretation of data; the writing of the manuscript;
the decision to submit the manuscript for publication. If the study sponsors had no such involvement, this
of
should be stated
Authors: All research done by the authors;
ro
Financial support: yes;
Author statement
re
-p
Re: Author statement on submission of revised manuscript titled “Medicinal plants
used by traditional medicine practitioners to boost the immune system in people
living with HIV/AIDS in Uganda.”
On behalf of my co-authors, I wish to state that all the comments made by the reviewers
ur
na
lP
of our manuscript have been duly attended to. A revised version of the manuscript has
been uploaded attached, together with other additional documents requested for by the
reviewer like the map of the study site. All the revisions have been highlighted in yellow.
A corresponding detailed response to the reviewer’s comments has also been uploaded
indicating point by point, the reviewer’s comments and the response made and where
exactly it is located in the manuscript
Conflict of interest: none
Jo
Conflict of Interest
A conflicting interest exists when professional judgement concerning a primary interest (such as patient’s
welfare or the validity of research) may be influenced by a secondary interest (such as financial gain or
personal rivalry). It may arise for the authors when they have financial interest that may influence their
interpretation of their results or those of others. Examples of potential conflicts of interest include
employment, consultancies, stock ownership, honoraria, paid expert testimony, patent
applications/registrations, and grants or other funding.
10
Word count: 3092 without references & abstract
Acknowledgement
This research was supported by the Consortium for Advanced Research Training in Africa
(CARTA). CARTA is jointly led by the African Population and Health Research Centre and
the University of the Witwatersrand and funded by the Carnegie Corporation of New York
(Grant No--B 8606.R02), Sida (Grant No: 54100113), the DELTAS Africa Initiative (Grant
No: 107768/Z/15/Z) and Deutscher Akademischer Austauschdienst (DAAD). The DELTAS
Africa Initiative is an independent funding scheme of the African Academy of Sciences
(AAS)’s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by
the New Partnership for Africa’s Development Planning and Coordinating Agency (NEPAD
of
Agency) with funding from the Wellcome Trust (UK) and the UK government.
The statements made and views expressed are solely the responsibility of the Fellow.
ro
We also acknowledge and thank the research assistants Kasozi Dauda, Kibuuka Sserwano
Moses, Kizito Medi, Onenarach Walter & Opio Henry, for their dedicated work. We are also
-p
grateful to the TMP who gave their consent to take part in this study and to share their
ur
na
lP
re
knowledge with us.
Jo
Reference:
[1] M.S. Al-Haddad, F. Hamam, S.M. Al-Shakhshir, General public knowledge,
perceptions and practice towards pharmaceutical drug advertisements in the Western
region
of
KSA,
Saudi
Pharm.
J.
22
(2014)
119–126.
https://doi.org/http://dx.doi.org/10.1016/j.jsps.2013.03.002.
[2] C.-C. Wen, H.-M. Chen, N.-S. Yang, Chapter 6 - Developing Phytocompounds from
Medicinal Plants as Immunomodulators, in: S. Lie-Fen, S.Y.L. Allan (Eds.), Adv. Bot.
Res.,
Academic
Press,
2012:
pp.
197–272.
https://doi.org/http://dx.doi.org/10.1016/B978-0-12-394591-4.00004-0.
[3] J.C. Gea-Banacloche, Immunomodulation, in: Princ. Mol. Med., Springer, 2006: pp.
893–904.
[4] A.J. McMichael, P. Borrow, G.D. Tomaras, N. Goonetilleke, B.F. Haynes, The immune
response during acute HIV-1 infection: clues for vaccine development, Nat Rev
Immunol. 10 (2010) 11–23. https://doi.org/10.1038/nri2674.
[5] K. Mukherjee, R. Biswas, S.K. Chaudhary, P.K. Mukherjee, Chapter 18 - Botanicals as
Medicinal Food and Their Effects against Obesity, in: P.K. Mukherjee (Ed.), EvidenceBased Valid. Herb. Med., Elsevier, Boston, 2015: pp. 373–403.
https://doi.org/https://doi.org/10.1016/B978-0-12-800874-4.00018-0.
[6] M.T. Sultan, M.S. Butt, M.M. Qayyum, H.A. Suleria, Immunity: plants as effective
mediators,
Crit
Rev
Food
Sci
Nutr.
54
(2014)
1298–1308.
11
[12]
[13]
[14]
[15]
[16]
[17]
Jo
[18]
of
[11]
ro
[10]
-p
[9]
re
[8]
ur
na
lP
[7]
https://doi.org/10.1080/10408398.2011.633249.
S. Raj, K.M. Gothandam, Immunomodulatory activity of methanolic extract of
Amorphophallus commutatus var. wayanadensis under normal and cyclophosphamide
induced immunosuppressive conditions in mice models, Food Chem Toxicol. 81 (2015)
151–159. https://doi.org/10.1016/j.fct.2015.04.026.
I. Jantan, W. Ahmad, S.N.A. Bukhari, Plant-derived immunomodulators: An insight on
their preclinical evaluation and clinical trials, Front. Plant Sci. 6 (2015).
https://doi.org/10.3389/fpls.2015.00655.
A. Puri, R. Saxena, R.P. Saxena, K.C. Saxena, V. Srivastava, J.S. Tandon,
Immunostimulant activity of Nyctanthes arbortristis L, J Ethnopharmacol. 42 (1994)
31–37. https://doi.org/10.1016/0378-8741(94)90020-5.
A. Saxena, S. Dixit, S. Aggarwal, V. Seenu, R. Prashad, S.M. Bhushan, V. Tranikanti,
M.C. Misra, A. Srivastava, An ayurvedic herbal compound to reduce toxicity to cancer
chemotherapy: a randomized controlled trial, Indian J. Med. Paediatr. Oncol. 29 (2008)
11.
G. Leroux-Roels, Unmet needs in modern vaccinology: Adjuvants to improve the
immune
response,
Vaccine.
28,
Supple
(2010)
C25–C36.
https://doi.org/http://dx.doi.org/10.1016/j.vaccine.2010.07.021.
S. Koo, F.M. Marty, L.R. Baden, Infectious Complications Associated with
Immunomodulating Biologic Agents, Infect. Dis. Clin. North Am. 24 (2010) 285–306.
https://doi.org/http://dx.doi.org/10.1016/j.idc.2010.01.006.
H.C.T. Lotter-Stark, E.P. Rybicki, R.K. Chikwamba, Plant made anti-HIV
microbicides—A field of opportunity, Biotechnol. Adv. 30 (2012) 1614–1626.
https://doi.org/http://dx.doi.org/10.1016/j.biotechadv.2012.06.002.
N. Oršolić, I. Bašić, Immunomodulation by water-soluble derivative of propolis: a factor
of
antitumor
reactivity,
J.
Ethnopharmacol.
84
(2003)
265–273.
https://doi.org/http://dx.doi.org/10.1016/S0378-8741(02)00329-X.
T. Fernandez, P. Cerda Zolezzi, E. Risco, V. Martino, P. Lopez, M. Clavin, O.
Hnatyszyn, S. Canigueral, S. Hajos, G. Ferraro, E. Alvarez, Immunomodulating
properties of Argentine plants with ethnomedicinal use, Phytomedicine. 9 (2002) 546–
552. https://doi.org/10.1078/09447110260573182.
J.E. Williams, Review of antiviral and immunomodulating properties of plants of the
Peruvian rainforest with a particular emphasis on Una de Gato and Sangre de Grado,
Altern Med Rev. 6 (2001) 567–579.
A. Puri, R. Sahai, K.L. Singh, R.P. Saxena, J.S. Tandon, K.C. Saxena, Immunostimulant
activity of dry fruits and plant materials used in Indian traditional medical system for
mothers after child birth and invalids, J. Ethnopharmacol. 71 (2000) 89–92.
https://doi.org/http://dx.doi.org/10.1016/S0378-8741(99)00181-6.
M. Karunai Raj, C. Balachandran, V. Duraipandiyan, P. Agastian, S. Ignacimuthu,
Antimicrobial activity of Ulopterol isolated from Toddalia asiatica (L.) Lam.: A
traditional medicinal plant, J. Ethnopharmacol. 140 (2012) 161–165.
https://doi.org/http://dx.doi.org/10.1016/j.jep.2012.01.005.
G.C. Prendergast, E.M. Jaffee, Cancer immunologists and cancer biologists: why we
didn’t talk then but need to now, Cancer Res. 67 (2007) 3500–3504.
https://doi.org/10.1158/0008-5472.can-06-4626.
K. Sak, Chemotherapy and dietary phytochemical agents. Chemother Res Pract 2012:
282570, (2012).
K. Peltzer, N. Friend-du-Preez, S. Ramlagan, H. Fomundam, J. Anderson, L. Chanesta,
Antiretrovirals and the use of traditional, complementary and alternative medicine
(TCAM) by HIV patients in Kwazulu-Natal, South Africa: a longitudinal study, Afr J
[19]
[20]
[21]
12
[27]
[28]
[29]
[30]
[31]
Jo
[32]
of
[26]
ro
[25]
-p
[24]
re
[23]
ur
na
lP
[22]
TraditComplentAltern Med. 8 (2011).
D. Davids, T. Blouws, O. Aboyade, D. Gibson, J.T. De Jong, C. Van’t Klooster, G.
Hughes, Traditional health practitioners’ perceptions, herbal treatment and management
of HIV and related opportunistic infections, J. Ethnobiol. Ethnomed. 10 (2014) 77.
https://doi.org/10.1186/1746-4269-10-77.
G. Anywar, E. Kakudidi, R. Byamukama, J. Mukonzo, A. Schubert, H. Oryem-Origa,
Indigenous traditional knowledge of medicinal plants used by herbalists in treating
opportunistic infections among people living with HIV/AIDS in Uganda, J.
Ethnopharmacol.
246
(2020)
112205.
https://doi.org/https://doi.org/10.1016/j.jep.2019.112205.
E. Gurmu Abyot, F.S. Teni, W.T. Tadesse, Pattern of Traditional Medicine Utilization
among HIV/AIDS Patients on Antiretroviral Therapy at a University Hospital in
Northwestern Ethiopia: A Cross-Sectional Study, Evidence-Based Complement. Altern.
Med. 2017 (2017) 6. https://doi.org/10.1155/2017/1724581.
K.T. Haile, A.A. Ayele, A.B. Mekuria, C.A. Demeke, B.M. Gebresillassie, D.A. Erku,
Traditional herbal medicine use among people living with HIV/AIDS in Gondar,
Ethiopia: Do their health care providers know?, Complement. Ther. Med. 35 (2017) 14–
19. https://doi.org/https://doi.org/10.1016/j.ctim.2017.08.019.
E. Mills, C. Cooper, D. Seely, I. Kanfer, African herbal medicines in the treatment of
HIV: Hypoxis and Sutherlandia. An overview of evidence and pharmacology, Nutr J. 4
(2005). https://doi.org/10.1186/1475-2891-4-19.
G.J. Martin, Ethnobotany: A methods manual, Hall, London, 1995.
https://doi.org/10.1007/978-1-4615-2496-0.
A.M. Mih, A.M. Ngone, L.M. Ndam, Assessment of nutritional composition of wild
vegetables consumed by the people of Lebialem Highlands, South Western Cameroon,
in: Food Nutr. Sci., 2017: pp. 647–657.
V.L. Suryavanshi, P.A. Sathe, M.M. Baing, G.R. Singh, S.N. Lakshmi, Determination
of rutin in Amaranthus spinosus Linn. Whole plant powder by HPTLC,
Chromatographia. 65 (2007) 767.
M. Sigamoney, S. Shaik, P. Govender, S.B.N. Krishna, Sershen, African leafy
vegetables as bio-factories for silver nanoparticles: A case study on Amaranthus dubius
C Mart. Ex Thell, South African J. Bot. 103 (2016) 230–240.
https://doi.org/https://doi.org/10.1016/j.sajb.2015.08.022.
F.O. Orech, T. Akenga, J. Ochora, H. Friis, J. Aagaard-Hansen, Potential toxicity of
some traditional leafy vegetables consumed in Nyang’oma Division, Western Kenya,
African J. Food, Agric. Nutr. Dev. 5 (2005).
P. Tugume, E.K. Kakudidi, M. Buyinza, J. Namaalwa, M. Kamatenesi, P. Mucunguzi,
J. Kalema, Ethnobotanical survey of medicinal plant species used by communities
around Mabira Central Forest Reserve, Uganda, J. Ethnobiol. Ethnomed. 12 (2016) 1–
28. https://doi.org/10.1186/s13002-015-0077-4.
M.M. Adia, G. Anywar, R. Byamukama, M. Kamatenesi-Mugisha, Y. Sekagya, E.K.
Kakudidi, B.T. Kiremire, Medicinal plants used in malaria treatment by Prometra
herbalists
in
Uganda,
J.
Ethnopharmacol.
155
(2014).
https://doi.org/10.1016/j.jep.2014.05.060.
E.G. Achigan-Dako, O.E.D. Sogbohossou, P. Maundu, Current knowledge on
Amaranthus spp.: research avenues for improved nutritional value and yield in leafy
amaranths in sub-Saharan Africa, Euphytica. 197 (2014) 303–317.
https://doi.org/10.1007/s10681-014-1081-9.
G. Kumar, L. Karthik, K.V.B. Rao, Phytochemical composition and in vitro antioxidant
activity of aqueous extract of Aerva lanata (L.) Juss. ex Schult. Stem (Amaranthaceae),
[33]
[34]
[35]
13
[41]
[42]
[43]
[44]
[45]
[46]
Jo
[47]
of
[40]
ro
[39]
-p
[38]
re
[37]
ur
na
lP
[36]
Asian
Pac.
J.
Trop.
Med.
6
(2013)
180–187.
https://doi.org/https://doi.org/10.1016/S1995-7645(13)60020-6.
K.G. Nevin, P.L. Vijayammal, Pharmacological and Immunomodulatory Effects of
Aerva lanata. in Daltons Lymphoma Ascites–Bearing Mice, Pharm. Biol. 43 (2005)
640–646. https://doi.org/10.1080/13880200500303858.
A. Sharma, M. Tanwar, N. Nagar, A.K. Sharma, Analgesic and anti-inflamatory activity
of flowers extract of Aerva lanata, Adv. Pharmacol. Toxicol. 12 (2011) 13–18.
http://search.ebscohost.com/login.aspx?direct=true&db=aph&AN=67516171&site=eh
ost-live.
D. Chowdhury, A. Sayeed, A. Islam, M. Shah Alam Bhuiyan, G.R.M. Astaq Mohal
Khan, Antimicrobial activity and cytotoxicity of Aerva lanata, Fitoterapia. 73 (2002)
92–94. https://doi.org/https://doi.org/10.1016/S0367-326X(01)00369-0.
S. Manokaran, A. Jaswanth, S. Sengottuvelu, J. Nandhakumar, R. Duraisamy, D.
Karthikeyan, R. Mallegaswari, Hepatoprotective activity of Aerva lanata Linn. against
paracetamol induced hepatotoxicity in rats, Res. J. Pharm. Technol. 1 (2008) 398–400.
R.P. Gujjeti, S. Namthabad, E. Mamidala, HIV-1 reverse transcriptase inhibitory
activity of Aerva lanata plant extracts, BMC Infect. Dis. 14 (2014) P12.
K. Devarai H., S. Oruganti K., S.B. Puttagunta, K. Ramadoss, In vitro anti tubercular
activity of leaves of Aerva lanata L, Int. Biol. Biomed. J. 3 (2017) 209–212.
http://ibbj.org/article-1-114-en.html.
K.S. Omotoso, F.R. Aigbe, O.A. Salako, M.C. Chijioke, O.O. Adeyemi, Toxicological
evaluation of the aqueous whole plant extract of Aerva lanata (l.) Juss. ex Schult
(Amaranthaceae),
J.
Ethnopharmacol.
208
(2017)
174–184.
https://doi.org/https://doi.org/10.1016/j.jep.2017.06.032.
N.D. Weber, D.O. Andersen, J.A. North, B.K. Murray, L.D. Lawson, B.G. Hughes, In
vitro virucidal effects of Allium sativum (garlic) extract and compounds, Planta Med. 58
(1992) 417–423. https://doi.org/10.1055/s-2006-961504.
N. Benkeblia, Antimicrobial activity of essential oil extracts of various onions (Allium
cepa) and garlic (Allium sativum), LWT - Food Sci. Technol. 37 (2004) 263–268.
https://doi.org/https://doi.org/10.1016/j.lwt.2003.09.001.
J.T. Pinto, S. Lapsia, A. Shah, H. Santiago, G. Kim, Antiproliferative effects of garlicderived and other Allium related compounds, in: Nutr. Cancer Prev. New Insights into
Role Phytochem., Springer US, Boston, MA, 2001: pp. 83–106.
https://doi.org/10.1007/978-1-4615-1283-7_8.
G. Schafer, C.H. Kaschula, The immunomodulation and anti-inflammatory effects of
garlic organosulfur compounds in cancer chemoprevention, Anticancer Agents Med
Chem. 14 (2014) 233–240.
F. Borrelli, R. Capasso, A.A. Izzo, Garlic (Allium sativum L.): Adverse effects and drug
interactions in humans, Mol. Nutr. Food Res. 51 (2007) 1386–1397.
https://doi.org/10.1002/mnfr.200700072.
K.D. Rose, P.D. Croissant, C.F. Parliament, M.B. Levin, Spontaneous spinal epidural
hematoma with associated platelet dysfunction from excessive garlic ingestion: a case
report, Neurosurgery. 26 (1990) 880–882.
E. Beck, J. Grunwald, Allium sativum in der stufentherapie der hyperlipidamie: studie
mit 1997 patienten belegt wirksamkeit und vertraglichkeit, Medizinische Welt. 44
(1993) 516–520.
P. Ssegawa, J.M. Kasenene, Medicinal plant diversity and uses in the Sango bay area,
Southern
Uganda,
J.
Ethnopharmacol.
113
(2007)
521–540.
https://doi.org/http://dx.doi.org/10.1016/j.jep.2007.07.014.
H.P. Koch, L.D. Lawson, Garlic: the science and therapeutic application of Allium
[48]
[49]
[50]
[51]
14
[57]
[58]
[59]
[60]
[61]
[62]
Jo
[63]
of
[56]
ro
[55]
-p
[54]
re
[53]
ur
na
lP
[52]
sativum L. and related species, Lippincott Williams & Wilkins, 1996.
J. Namukobe, J.M. Kasenene, B.T. Kiremire, R. Byamukama, M. Kamatenesi-Mugisha,
S. Krief, V. Dumontet, J.D. Kabasa, Traditional plants used for medicinal purposes by
local communities around the Northern sector of Kibale National Park, Uganda, J.
Ethnopharmacol.
136
(2011)
236–245.
https://doi.org/http://dx.doi.org/10.1016/j.jep.2011.04.044.
D. Prakash, B.N. Singh, G. Upadhyay, Antioxidant and free radical scavenging activities
of phenols from onion (Allium cepa), Food Chem. 102 (2007) 1389–1393.
https://doi.org/https://doi.org/10.1016/j.foodchem.2006.06.063.
V.P. Kumar, K.V.H. Prashanth, Y.P. Venkatesh, Structural analyses and
immunomodulatory properties of fructo-oligosaccharides from onion (Allium cepa),
Carbohydr.
Polym.
117
(2015)
115–122.
https://doi.org/https://doi.org/10.1016/j.carbpol.2014.09.039.
A.P.S. Votto, B.S. Domingues, M.M. de Souza, F.M.R. da Silva Júnior, S.S. Caldas, D.
Filgueira, R.M. Clementin, E.G. Primel, A.L. Vallochi, E.B. Furlong, Toxicity
mechanisms of onion (Allium cepa) extracts and compounds in multidrug resistant
erythroleukemic cell line, Biol. Res. 43 (2010) 429–437.
J.M. Nguta, R. Appiah-Opong, A.K. Nyarko, D. Yeboah-Manu, P.G.A. Addo,
Medicinal plants used to treat TB in Ghana, Int. J. Mycobacteriology. 4 (2015) 116–123.
https://doi.org/https://doi.org/10.1016/j.ijmyco.2015.02.003.
J.R.S. Tabuti, Herbal medicines used in the treatment of malaria in Budiope county,
Uganda,
J.
Ethnopharmacol.
116
(2008)
33–42.
https://doi.org/http://dx.doi.org/10.1016/j.jep.2007.10.036.
W.M. Kone, D. Soro, B. Dro, K. Yao, K. Kamanzi, Chemical composition, antioxidant,
antimicrobial and acetylcholinesterase inhibitory properties of Lannea barteri
(Anacardiaceae), Aust. J Basic App Sci. 5 (2011) 1516–1523.
N.S. Njinga, M.I. Sule, U.U. Pateh, H.S. Hassan, M.M. Ahmad, S.T. Abdullahi, B.A.
Danja, B. Bawa, Phytochemical and antimicrobial activity of Lannea kerstingii Engl and
K. Krause (Anacadiaceae), Nitte Univ. J. Heal. Sci. 4 (2014) 4–9.
S.A. Adegoke, F.O. Agada, L. Ogundipe, Antibacterial activity of methanol and ethanol
leaf extracts of Antidesma venosum and Lannea barteri, Afr. J. Microbiol. Res. 7 (2013)
3442–3447.
K. Garba, A.H. Yaro, J. Ya’u, Anticonvulsant effects of ethanol stem bark extract of
Lannea barteri (Anacardiaceae) in mice and chicks, J. Ethnopharmacol. 172 (2015)
227–231. https://doi.org/https://doi.org/10.1016/j.jep.2015.06.039.
U.I. Nda-Umar, M. Gbate, A.N. Umar, Y.M. Alfa, A. Mann, Phytochemical and acute
toxicity studies of methanolic extracts of selected antimalarial plants of Nupeland, north
central Nigeria, J. Med. Plants Res. 11 (2017) 351–356.
P. Scartezzini, E. Speroni, Review on some plants of Indian traditional medicine with
antioxidant activity, J Ethnopharmacol. 71 (2000) 23–43.
D. Singh, P. V Arya, A. Sharma, M.P. Dobhal, R.S. Gupta, Modulatory potential of αamyrin against hepatic oxidative stress through antioxidant status in wistar albino rats,
J.
Ethnopharmacol.
161
(2015)
186–193.
https://doi.org/http://dx.doi.org/10.1016/j.jep.2014.12.025.
A.J. Núñez-Sellés, Antioxidant therapy: myth or reality?, J. Braz. Chem. Soc. 16 (2005)
699–710.
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S010350532005000500004&nrm=iso.
Y. Zhang, J. Li, Z. Wu, E. Liu, P. Shi, L. Han, L. Guo, X. Gao, T. Wang, Acute and
long-term toxicity of mango leaves extract in mice and rats, Evidence-Based
Complement. Altern. Med. 2014 (2014).
[64]
[65]
[66]
15
Jo
ur
na
lP
re
-p
ro
of
[67] R.A. Reddeman, R. Glávits, J.R. Endres, A.E. Clewell, G. Hirka, A. Vértesi, E. Béres,
I.P. Szakonyiné, A Toxicological Evaluation of Mango Leaf Extract (Mangifera indica)
Containing 60% Mangiferin, J. Toxicol. 2019 (2019).
[68] Y.M. Lin, H. Anderson, M.T. Flavin, Y.H. Pai, E. Mata-Greenwood, T. Pengsuparp,
J.M. Pezzuto, R.F. Schinazi, S.H. Hughes, F.C. Chen, In vitro anti-HIV activity of
biflavonoids isolated from Rhus succedanea and Garcinia multiflora, J Nat Prod. 60
(1997) 884–888. https://doi.org/10.1021/np9700275.
[69] Y.M. Lin, M.T. Flavin, R. Schure, F.C. Chen, R. Sidwell, D.L. Barnard, J.H. Huffman,
E.R. Kern, Antiviral activities of biflavonoids, Planta Med. 65 (1999) 120–125.
https://doi.org/10.1055/s-1999-13971.
[70] M. Lamorde, J.R.S. Tabuti, C. Obua, C. Kukunda-Byobona, H. Lanyero, P. ByakikaKibwika, G.S. Bbosa, A. Lubega, J. Ogwal-Okeng, M. Ryan, P.J. Waako, C. Merry,
Medicinal plants used by traditional medicine practitioners for the treatment of
HIV/AIDS and related conditions in Uganda, J. Ethnopharmacol. 130 (2010) 43–53.
https://doi.org/http://dx.doi.org/10.1016/j.jep.2010.04.004.
[71] J.O. Kokwaro, No Title, in: Med. Plants East Africa, Kenya Literature Bureau; Nairobi,
Kenya, 1993.
[72] M.J. Moshi, E. Innocent, J.J. Magadula, D.F. Otieno, A. Weisheit, P.K. Mbabazi, R.S.O.
Nondo, Brine Shrimp of Some Plants used as Traditional Medicine in Kagera Region,
Northw
West
Tanzania,
Tanzan.
J.
Health
Res.
12
(2010).
https://doi.org/10.4314/thrb.v12i1.56287.
[73] K.J. Kwon, S. Bae, K. Kim, I.S. An, K.J. Ahn, S. An, H.J. Cha, Asiaticoside, a
component of Centella asiatica, inhibits melanogenesis in B16F10 mouse melanoma,
Mol. Med. Rep. 10 (2014) 503–507.
[74] I.K. Srivastava, A.B. Vaidya, A mechanism for the synergistic antimalarial action of
atovaquone and proguanil, Antimicrob Agents Chemother. 43 (1999).
[75] K. Punturee, C.P. Wild, W. Kasinrerk, U. Vinitketkumnuen, Immunomodulatory
activities of Centella asiatica and Rhinacanthus nasutus extracts, Asian Pac J Cancer
Prev. 6 (2005) 396–400.
[76] P.K. Chauhan, V. Singh, Acute and Subacute Toxicity study of the Acetone Leaf extract
of Centella asiatica in Experimental Animal Models, Asian Pac. J. Trop. Biomed. 2
(2012) S511–S513. https://doi.org/https://doi.org/10.1016/S2221-1691(12)60263-9.
[77] T.D. Babu, G. Kuttan, J. Padikkala, Cytotoxic and anti-tumour properties of certain taxa
of Umbelliferae with special reference to Centella asiatica (L.) Urban, J.
Ethnopharmacol. 48 (1995) 53–57. https://doi.org/https://doi.org/10.1016/03788741(95)01284-K.
[78] M.M. Adia, S.N. Emami, R. Byamukama, I. Faye, A.-K. Borg-Karlson, Antiplasmodial
activity and phytochemical analysis of extracts from selected Ugandan medicinal plants,
J.
Ethnopharmacol.
186
(2016)
14–19.
https://doi.org/http://dx.doi.org/10.1016/j.jep.2016.03.047.
[79] A. Nyamukuru, J.R.S. Tabuti, M. Lamorde, B. Kato, Y. Sekagya, P.R. Aduma,
Medicinal plants and traditional treatment practices used in the management of
HIV/AIDS clients in Mpigi District, Uganda, J. Herb. Med. 7 (2017) 51–58.
https://doi.org/https://doi.org/10.1016/j.hermed.2016.10.001.
[80] E. Elisabetsky, L. Costa-Campos, The Alkaloid Alstonine: A Review of Its
Pharmacological Properties, Evid Based Complement Altern. Med. 3 (2006) 39–48.
https://doi.org/10.1093/ecam/nek011.
[81] M.O. Obiagwu, C.P. Ihekwereme, D.L. Ajaghaku, F.B.C. Okoye, The Useful Medicinal
Properties of the Root-Bark Extract of Alstonia boonei (Apocynaceae) May Be
Connected to Antioxidant Activity, ISRN Pharmacol. 2014 (2014) 4.
16
[87]
[88]
[89]
[90]
[91]
[92]
[93]
Jo
[94]
of
[86]
ro
[85]
-p
[84]
re
[83]
ur
na
lP
[82]
https://doi.org/10.1155/2014/741478.
G. Kweifio-Okai, A.R. Carroll, Antiarthritic effect of lupeol acetate, Phyther. Res. 7
(1993) 213–215. https://doi.org/doi:10.1002/ptr.2650070227.
A. Rajic, G. Kweifio-Okai, T. Macrides, R.M. Sandeman, D.S. Chandler, G.M. Polya,
Inhibition of serine proteases by anti-inflammatory triterpenoids, Planta Med. 66 (2000)
206–210. https://doi.org/10.1055/s-2000-8657.
B.L.N.Y. Nkono, S.D. Sokeng, D.D.P. Désiré, L. Frida, P. Kamtchouing, Subchronic
toxicity of aqueous extract of Alstonia boonei de wild. (Apocynaceae) stem bark in
normal rats, (2014).
J. Olanlokun, O. Olorunsogo, Toxicology of solvent extract and fractions of Alstonia
boonei (DC.) Wild stem bark in rats, J. Herbmed Pharmacol. 7 (2018).
M.M. Iwu, D.L. Kiayman, Evaluation of the in vitro antimalarial activity of Picralima
nitida extracts, J. Ethnopharmacol. 36 (1992) 133–135.
A. Paulo, E.T. Gomes, J. Steele, D.C. Warhurst, P.J. Houghton, Antiplasmodial activity
of Cryptolepis sanguinolenta alkaloids from leaves and roots, Planta Med. 66 (2000)
30–34. https://doi.org/10.1055/s-2000-11106.
L. Bunalema, C. Kirimuhuzya, J.R. Tabuti, P. Waako, J.J. Magadula, N. Otieno, J.A.
Orodho, P. Okemo, The efficacy of the crude root bark extracts of Erythrina abyssinica
on rifampicin resistant Mycobacterium tuberculosis, Afr Heal. Sci. 11 (2011) 587–593.
F.C. Mills-Robertson, S.C.K. Tay, G. Duker-Eshun, W. Walana, K. Badu, In vitro
antimicrobial activity of ethanolic fractions of Cryptolepis sanguinolenta, Ann. Clin.
Microbiol. Antimicrob. 11 (2012) 16. https://doi.org/10.1186/1476-0711-11-16.
D.E. Bierer, D.M. Fort, C.D. Mendez, J. Luo, P.A. Imbach, L.G. Dubenko, S.D. Jolad,
R.E. Gerber, J. Litvak, Q. Lu, P. Zhang, M.J. Reed, N. Waldeck, R.C. Bruening, B.K.
Noamesi, R.F. Hector, T.J. Carlson, S.R. King, Ethnobotanical-directed discovery of the
antihyperglycemic properties of cryptolepine: its isolation from Cryptolepis
sanguinolenta, synthesis, and in vitro and in vivo activities, J Med Chem. 41 (1998)
894–901. https://doi.org/10.1021/jm9704816.
C. Ansah, H.R. Otsyina, M. Duwiejua, E. Woode, F.A. Aboagye, K.G. Aning,
Toxicological assessment of Cryptolepis sanguinolenta for possible use in veterinary
medicine, J. Vet. Med. Anim. Heal. 1 (2009) 11–16.
C. Ansah, N.J. Gooderham, The popular herbal antimalarial, extract of Cryptolepis
sanguinolenta, is potently cytotoxic, Toxicol Sci. 70 (2002) 245–251.
https://doi.org/10.1093/toxsci/70.2.245.
E.N. Matu, J. van Staden, Antibacterial and anti-inflammatory activities of some plants
used for medicinal purposes in Kenya, J Ethnopharmacol. 87 (2003) 35–41.
A.O. Aremu, L. Cheesman, J.F. Finnie, J. Van Staden, Mondia whitei (Apocynaceae):
A review of its biological activities, conservation strategies and economic potential,
South
African
J.
Bot.
77
(2011)
960–971.
https://doi.org/http://dx.doi.org/10.1016/j.sajb.2011.06.010.
A. Bouba, Y.N. Njintang, J. Scher, C.M.F. Mbofung, Phenolic compounds and radical
scavenging potential of twenty Cameroonian spices, Agric. Biol. J. North Am. 1 (2010)
213–224.
O. Joseph, T.J. Kihdze, B. Katusiime, L. Imanirampa, P. Waako, F. Bajunirwe, A.A.
Ganafa, Toxicity of four herbs used in erectile dysfunction; Mondia whiteii, Cola
acuminata, Urtica massaica and Tarenna graveolensin in male rats, African J. Pharm.
Pharmacol. 9 (2015) 756–763.
D.P. Kisangau, K.M. Hosea, H.V.M. Lyaruu, C.C. Joseph, Z.H. Mbwambo, P.J.
Masimba, C.B. Gwandu, L.N. Bruno, K.P. Devkota, N. Sewald, Screening of
traditionally used Tanzanian medicinal plants for antifungal activity, Pharm. Biol. 47
[95]
[96]
[97]
17
[103]
[104]
[105]
[106]
[107]
[108]
Jo
[109]
of
[102]
ro
[101]
-p
[100]
re
[99]
ur
na
lP
[98]
(2009) 708–716. https://doi.org/10.1080/13880200902933039.
J.F. Ferreira, D.L. Luthria, T. Sasaki, A. Heyerick, Flavonoids from Artemisia annua L.
as antioxidants and their potential synergism with artemisinin against malaria and cancer,
Molecules. 15 (2010) 3135–3170. https://doi.org/10.3390/molecules15053135.
K.C.-S.C. Liu, S.-L.L. Yang, M.F. Roberts, B.C. Elford, J.D. Phillipson, Antimalarial
activity of Artemisia annua flavonoids from whole plants and cell cultures, Plant Cell
Rep. 11 (1992) 637–640. https://doi.org/10.1007/BF00236389.
S. Ćavar, M. Maksimović, D. Vidic, A. Parić, Chemical composition and antioxidant
and antimicrobial activity of essential oil of Artemisia annua L. from Bosnia, Ind. Crops
Prod. 37 (2012) 479–485. https://doi.org/https://doi.org/10.1016/j.indcrop.2011.07.024.
T. Efferth, Willmar Schwabe Award 2006: antiplasmodial and antitumor activity of
artemisinin--from bench to bedside, Planta Med. 73 (2007) 299–309.
https://doi.org/10.1055/s-2007-967138.
M. Siddiqui, S.P. Waghmare, S.W. Hajare, R.S.I.S.G. Deshmukh, S.D.C.S.A. Ali,
Phytochemical analysis and acute toxicity studies of Artemisia annua in Swiss albino
mice, J. Pharmacogn. Phytochem. 7 (2018) 1893–1895.
N.S. Radulović, P.J. Randjelović, N.M. Stojanović, P.D. Blagojević, Z.Z. StojanovićRadić, I.R. Ilić, V.B. Djordjević, Toxic essential oils. Part II: Chemical, toxicological,
pharmacological and microbiological profiles of Artemisia annua L. volatiles, Food
Chem.
Toxicol.
58
(2013)
37–49.
https://doi.org/https://doi.org/10.1016/j.fct.2013.04.016.
T. Gordi, E.-I. Lepist, Artemisinin derivatives: toxic for laboratory animals, safe for
humans?,
Toxicol.
Lett.
147
(2004)
99–107.
https://doi.org/https://doi.org/10.1016/j.toxlet.2003.12.009.
H. Liu, X. Tian, Y. Zhang, C. Wang, H. Jiang, The discovery of Artemisia annua L. in
the Shengjindian cemetery, Xinjiang, China and its implications for early uses of
traditional Chinese herbal medicine qinghao, J Ethnopharmacol. 146 (2013) 278–286.
https://doi.org/10.1016/j.jep.2012.12.044.
X.J. Yao, M.A. Wainberg, M.A. Parniak, Mechanism of inhibition of HIV-1 infection
in vitro by purified extract of Prunella vulgaris, Virology. 187 (1992) 56–62.
J. Carlotto, L.M. de Souza, C.H. Baggio, M.F. Werner, D. Maria-Ferreira, G.L. Sassaki,
M. Iacomini, T.R. Cipriani, Polysaccharides from Arctium lappa L.: Chemical structure
and biological activity, Int J Biol Macromol. 91 (2016) 954–960.
https://doi.org/10.1016/j.ijbiomac.2016.06.033.
H. Namdar Ahmadabad, M. Behnamfar, M. Nezafat Firizi, S. Saghayan, F. Taghasi, A.
Abbaspur, Comparison of the Immunomodulatory Properties of Root and Leaves of
Arctium Lappa (Burdock) in Vitro, Zahedan J Res Med Sci. 19 (2017).
M. Takasugi, S. Kawashima, N. Katsui, A. Shirata, Two polyacetylenic phytoalexins
from
Arctium
lappa,
Phytochemistry.
26
(1987)
2957–2958.
https://doi.org/https://doi.org/10.1016/S0031-9422(00)84570-7.
S. Su, M. Wink, Natural lignans from Arctium lappa as antiaging agents in
Caenorhabditis
elegans,
Phytochemistry.
117
(2015)
340–350.
https://doi.org/10.1016/j.phytochem.2015.06.021.
J. Cao, C. Li, P. Zhang, X. Cao, T. Huang, Y. Bai, K. Chen, Antidiabetic effect of
burdock (Arctium lappa L.) root ethanolic extract on streptozotocin-induced diabetic
rats, African J. Biotechnol. 11 (2012) 9079–9085.
M. Yaghoubi, T. Rastegar, G. Amin, Safety Assessment of Arctium lappa L. Fruit
Extract in Female Wistar Rats: Acute and repeated oral toxicity studies, Res. J.
Pharmacogn. 6 (2019) 39–48.
European Medicines Agency, Assessment report on Arctium lappa L., radix, 2010.
[110]
[111]
[112]
[113]
18
Jo
ur
na
lP
re
-p
ro
of
[114] S. Jeelani, M.A. Khuroo, Triterpenoids from Arctium lappa, Nat Prod Res. 26 (2012)
654–658. https://doi.org/10.1080/14786419.2010.541886.
[115] N.J. Gakunga, K. Mugisha, D. Owiny, P. Waako, Effects of crude aqueous leaf extracts
of Citropsis articulata and Mystroxylon aethiopicum on sex hormone levels in male
albino rats, Int. J. Pharm. Sci. Invent. 3 (2014) 5–17.
[116] N.E. El-Ashmawy, E.A. El-Zamarany, M.L. Salem, H.A. El-Bahrawy, G.M. AlAshmawy, In vitro and in vivo studies of the immunomodulatory effect of Echinacea
purpurea on dendritic cells, J. Genet. Eng. Biotechnol. 13 (2015) 185–192.
https://doi.org/http://dx.doi.org/10.1016/j.jgeb.2015.05.002.
[117] J. Hudson, S. Vimalanathan, Echinacea—A Source of potent antivirals for Respiratory
Virus
Infections,
Pharmaceuticals.
4
(2011)
1019–1031.
https://doi.org/10.3390/ph4071019.
[118] J.B. Hudson, Applications of the phytomedicine Echinacea purpurea (Purple
Coneflower) in infectious diseases, J Biomed Biotechnol. 2012 (2012) 769896.
https://doi.org/10.1155/2012/769896.
[119] J. Barnes, L.A. Anderson, S. Gibbons, J.D. Phillipson, Echinacea species (Echinacea
angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt., Echinacea purpurea (L.)
Moench): a review of their chemistry, pharmacology and clinical properties, J Pharm
Pharmacol. 57 (2005) 929–954. https://doi.org/10.1211/0022357056127.
[120] U. Mengs, C.B. Clare, J.A. Poiley, Toxicity of Echinacea purpurea. Acute, subacute
and genotoxicity studies., Arzneimittelforschung. 41 (1991) 1076–1081.
[121] S. Ahmed, M.S. Ahmad, M. Yousaf, M. Nur-e-Alam, A.J. Al-Rehaily, Two New
Sesquiterpene Alcohols Isolated from Senecio hadiensis Forssk. Grown in Saudi Arabia,
Chem. Biodivers. 14 (2017) e1700144. https://doi.org/doi:10.1002/cbdv.201700144.
[122] O. Were, M. Benn, R.M. Munavu, Pyrrolizidine Alkaloids from Senecio hadiensis, J.
Nat. Prod. 54 (1991) 491–499. https://doi.org/10.1021/np50074a022.
[123] T. Chen, N. Mei, P.P. Fu, Genotoxicity of pyrrolizidine alkaloids, J. Appl. Toxicol. An
Int. J. 30 (2010) 183–196.
[124] H. Wiedenfeld, J. Edgar, Toxicity of pyrrolizidine alkaloids to humans and ruminants,
Phytochem. Rev. 10 (2011) 137–151.
[125] S. Asiimwe, A. Namutebi, A. Borg-Karlsson, M. Kamatenesi-Mugisha, H. OryemOriga, Documentation and Consensus of Indigenous knowledge on medicinal plants
used by the local communities in Western Uganda, J Nat Prod Pl Res. 4 (2014).
[126] S.T. Esubalew, A. Belete, E. Lulekal, T. Gabriel, E. Engidawork, K. Asres, Review of
Ethnobotanical and Ethnopharmacological Evidences of some Ethiopian Medicinal
Plants traditionally used for the Treatment of Cancer, Ethiop. J. Heal. Dev. 31 (2017)
161–187.
[127] J.J. Kiplimo, N.A. Koorbanally, H. Chenia, Triterpenoids from Vernonia auriculifera
Hiern exhibit antimicrobial activity, African J. Pharm. Pharmacol. 5 (2011) 1150–1156.
[128] J.M. Keriko, S. Nakajima, N. Baba, Y. Isozaki, K. Ikeda, J. Iwasa, P.N. Karanja, A plant
growth regulator from Vernonia auriculifera (Asteraceae), Zeitschrift Für Naturforsch.
C. 50 (1995) 455–458.
[129] N.J. Toyang, E.N. Ateh, H. Davis, P. Tane, L.B. Sondengam, J. Bryant, R. Verpoorte,
In vivo antiprostate tumor potential of Vernonia guineensis Benth. (Asteraceae) tuber
extract (VGDE) and the cytotoxicity of its major compound pentaisovaleryl sucrose, J.
Ethnopharmacol.
150
(2013)
724–728.
https://doi.org/http://dx.doi.org/10.1016/j.jep.2013.09.028.
[130] C.N. Muthaura, G.M. Rukunga, S.C. Chhabra, G.M. Mungai, E.N.M. Njagi, Traditional
antimalarial phytotherapy remedies used by the Kwale community of the Kenyan Coast,
J.
Ethnopharmacol.
114
(2007)
377–386.
19
[136]
[137]
[138]
[139]
[140]
[141]
[142]
Jo
[143]
of
[135]
ro
[134]
-p
[133]
re
[132]
ur
na
lP
[131]
https://doi.org/http://dx.doi.org/10.1016/j.jep.2007.08.033.
S.A. Deshmukh, D.K. Gaikwad, A review of the taxonomy, ethnobotany,
phytochemistry and pharmacology of Basella alba (Basellaceae), J. Appl. Pharm. Sci. 4
(2014) 153–165.
S. Kumar, A.K. Prasad, S. V Iyer, S.K. Vaidya, Systematic pharmacognostical,
phytochemical and pharmacological review on an ethno medicinal plant, Basella alba
L, J. Pharmacogn. Phyther. 5 (2013) 53–58.
O.J. Owolabi, E.K.I. Omogbai, O. Obasuyi, Antifungal and antibacterial activities of the
ethanolic and aqueous extract of Kigelia africana (Bignoniaceae) stem bark, African J.
Biotechnol. 6 (2007).
P.K.M. Nagarathna, K. Reena, S. Reddy, J. Wesley, Evaluation of Immunomodulatory
activity of the flavanoid from Kigelia africana, Indian J. Pharm. Biol. Res. 2 (2014) 41.
H.M. Farah, A.M. El Hussein, H.E. Khalid, H.M. Osman, Toxicity of Kigelia africana
Fruit in Rats, Adv. Res. (2017) 1–9.
S.W. Hassan, M.G. Abubakar, R.A. Umar, A.S. Yakubu, H.M. Maishanu, G. Ayeni,
Pharmacological and toxicological properties of leaf extracts of Kingelia africana
(bignoniaceae), J Pharmacol Toxicol. 6 (2011) 124–132.
M.R. Kernan, A. Amarquaye, J.L. Chen, J. Chan, D.F. Sesin, N. Parkinson, Z. Ye, M.
Barrett, C. Bales, C.A. Stoddart, B. Sloan, P. Blanc, C. Limbach, S. Mrisho, E.J. Rozhon,
Antiviral Phenylpropanoid Glycosides from the Medicinal Plant Markhamia lutea, J.
Nat. Prod. 61 (1998) 564–570. https://doi.org/10.1021/np9703914.
D. Lacroix, S. Prado, A. Deville, S. Krief, V. Dumontet, J. Kasenene, E. Mouray, C.
Bories, B. Bodo, Hydroperoxy-cycloartane triterpenoids from the leaves of Markhamia
lutea, a plant ingested by wild chimpanzees, Phytochemistry. 70 (2009) 1239–1245.
https://doi.org/https://doi.org/10.1016/j.phytochem.2009.06.020.
R.A. El Dib, A.H. Gaara, S.M. El-Shenawy, J.A.A. Micky, A.A. Mohammed, M.S.
Marzouk, Leaf extract of Markhamia platycalyx: polyphenolic profile, acute toxicity,
anti-inflammatory, hepatoprotective and in vitro antioxidant activities, Drug Res.
(Stuttg). 64 (2014) 680–689.
B. Onegi, C. Kraft, I. Kohler, M. Freund, K. Jenett-Siems, K. Siems, G. Beyer, M.F.
Melzig, U. Bienzle, E. Eich, Antiplasmodial activity of naphthoquinones and one
anthraquinone from Stereospermum kunthianum, Phytochemistry. 60 (2002) 39–44.
S.F. van Vuuren, A.M. Viljoen, The in vitro antimicrobial activity of toothbrush sticks
used in
Ethiopia,
South
African
J. Bot.
72 (2006) 646–648.
https://doi.org/https://doi.org/10.1016/j.sajb.2006.03.009.
F.P. Ching, E.K.I. Omogbai, S.O. Okpo, R.I. Ozolua, Antiinflammatory Activity of
Aqueous Extract of Stereospermum kunthianum (Cham, Sandrine Petit) Stem Bark in
Rats, Indian J Pharm Sci. 71 (2009) 106–110. https://doi.org/10.4103/0250-474x.51943.
M.S. Aliyu, U.A. Hanwa, M.B. Tijjani, A.B. Aliyu, B. Ya’u, Phytochemical and
antibacterial properties of leaf extract of Stereospermum kunthianum (Bignoniaceae),
Niger. J. Basic Appl. Sci. 17 (2009) 235–239.
F.P. Ching, E.K.I. Omogbai, Effects of sub acute oral administration of aqueous extract
of Stereospermum kunthianum (Bignoniaceae) stem bark on body weight and
haematological indices of rats, J. Pharm. Bioresour. 7 (2010) 127–131.
P. Ngure, Z. Ng’ang’a, A. Kimutai, S. Kepha, S. Mong’are, J. Ingonga, W. Tonui,
Immunostimulatory responses to crude extracts of Warburgia ugandensis (Sprague)
subsp ugandensis (Canellaceae) by BALB/c mice infected with Leishmania major, Pan
Afr Med J. 17 Suppl 1 (2014) 15. https://doi.org/10.11694/pamj.supp.2014.17.1.3638.
P.G. Mwitari, P.A. Ayeka, J. Ondicho, E.N. Matu, C.C. Bii, Antimicrobial activity and
probable mechanisms of action of medicinal plants of Kenya: Withania somnifera,
[144]
[145]
[146]
20
[152]
[153]
[154]
[155]
[156]
[157]
Jo
[158]
of
[151]
ro
[150]
-p
[149]
re
[148]
ur
na
lP
[147]
Warbugia ugandensis, Prunus africana and Plectrunthus barbatus, PLoS One. 8 (2013)
e65619. https://doi.org/10.1371/journal.pone.0065619.
S. Zschocke, T. Rabe, J.L. Taylor, A.K. Jager, J. van Staden, Plant part substitution-a
way to conserve endangered medicinal plants?, J Ethnopharmacol. 71 (2000) 281–292.
D. Kioy, A.I. Gray, P.G. Waterman, A comparative study of the stem-bark drimane
sesquiterpenes and leaf volatile oils of Warburgia ugandensis and W. Stuhlmannii,
Phytochemistry. 29 (1990) 3535–3538. https://doi.org/https://doi.org/10.1016/00319422(90)85270-P.
A.A. Wube, F. Bucar, S. Gibbons, K. Asres, Sesquiterpenes from Warburgia ugandensis
and their antimycobacterial activity, Phytochemistry. 66 (2005) 2309–2315.
https://doi.org/10.1016/j.phytochem.2005.07.018.
L.W. Karani, F.M. Tolo, S.M. Karanja, C. Khayeka−Wandabwa, Safety of Prunus
africana and Warburgia ugandensis in asthma treatment, South African J. Bot. 88
(2013) 183–190. https://doi.org/https://doi.org/10.1016/j.sajb.2013.07.007.
J.R. Tabuti, S.S. Dhillion, K.A. Lye, Traditional medicine in Bulamogi county, Uganda:
its practitioners, users and viability, J Ethnopharmacol. 85 (2003) 119–129.
V. Steenkamp, E. Mathivha, M.C. Gouws, C.E.J. van Rensburg, Studies on antibacterial,
antioxidant and fibroblast growth stimulation of wound healing remedies from South
Africa,
J
Ethnopharmacol.
95
(2004)
353–357.
https://doi.org/10.1016/j.jep.2004.08.020.
T.G. Dekker, T.D. Fourie, E. Matthee, F.O. Snyckers, An oxindole from the roots of
Capparis
tomentosa,
Phytochemistry.
26
(1987)
1845–1846.
https://doi.org/https://doi.org/10.1016/S0031-9422(00)82305-5.
O.M.M. Ahmed, S.E.I. Adam, The toxicity of Capparis tomentosa in goats, J. Comp.
Pathol.
90
(1980)
187–195.
https://doi.org/https://doi.org/10.1016/00219975(80)90055-9.
O.M. Ahmed, S.E. Adam, G.T. Edds, The toxicity of Capparis tomentosa in sheep and
calves., Vet. Hum. Toxicol. 23 (1981) 403–409.
K.C. Chinsembu, Ethnobotanical Study of Plants Used in the Management of
HIV/AIDS-Related Diseases in Livingstone, Southern Province, Zambia, EvidenceBased
Complement.
Altern.
Med.
2016
(2016)
14.
https://doi.org/10.1155/2016/4238625.
H. Okatch, B. Ngwenya, K.M. Raletamo, K. Andrae-Marobela, Determination of
potentially toxic heavy metals in traditionally used medicinal plants for HIV/AIDS
opportunistic infections in Ngamiland District in Northern Botswana, Anal. Chim. Acta.
730 (2012) 42–48. https://doi.org/http://dx.doi.org/10.1016/j.aca.2011.11.067.
A.T. El-Alfy, K. Ivey, K. Robinson, S. Ahmed, M. Radwan, D. Slade, I. Khan, M.
ElSohly, S. Ross, Antidepressant-like effect of delta9-tetrahydrocannabinol and other
cannabinoids isolated from Cannabis sativa L, Pharmacol Biochem Behav. 95 (2010)
434–442. https://doi.org/10.1016/j.pbb.2010.03.004.
E.M. Rock, C.L. Limebeer, R. Navaratnam, M.A. Sticht, N. Bonner, K. Engeland, R.
Downey, H. Morris, M. Jackson, L.A. Parker, A comparison of cannabidiolic acid with
other treatments for anticipatory nausea using a rat model of contextually elicited
conditioned
gaping,
Psychopharmacol.
231
(2014)
3207–3215.
https://doi.org/10.1007/s00213-014-3498-1.
S. Maione, F. Piscitelli, L. Gatta, D. Vita, L. De Petrocellis, E. Palazzo, V. de Novellis,
V. Di Marzo, Non-psychoactive cannabinoids modulate the descending pathway of
antinociception in anaesthetized rats through several mechanisms of action, Br J
Pharmacol. 162 (2011) 584–596. https://doi.org/10.1111/j.1476-5381.2010.01063.x.
E.S. Raborn, M. Jamerson, F. Marciano-Cabral, G.A. Cabral, Cannabinoid inhibits HIV-
[159]
[160]
[161]
21
[167]
[168]
[169]
[170]
[171]
[172]
Jo
[173]
of
[166]
ro
[165]
-p
[164]
re
[163]
ur
na
lP
[162]
1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins,
Life Sci. 104 (2014) 15–23. https://doi.org/10.1016/j.lfs.2014.04.008.
X. Yang, V.L. Hegde, R. Rao, J. Zhang, P.S. Nagarkatti, M. Nagarkatti, Histone
modifications are associated with Delta9-tetrahydrocannabinol-mediated alterations in
antigen-specific T cell responses, J Biol Chem. 289 (2014) 18707–18718.
https://doi.org/10.1074/jbc.M113.545210.
R. Ramer, S. Fischer, M. Haustein, K. Manda, B. Hinz, Cannabinoids inhibit angiogenic
capacities of endothelial cells via release of tissue inhibitor of matrix
metalloproteinases-1 from lung cancer cells, Biochem Pharmacol. 91 (2014) 202–216.
https://doi.org/10.1016/j.bcp.2014.06.017.
G. Appendino, S. Gibbons, A. Giana, A. Pagani, G. Grassi, M. Stavri, E. Smith, M.M.
Rahman, Antibacterial cannabinoids from Cannabis sativa: a structure-activity study, J
Nat Prod. 71 (2008) 1427–1430. https://doi.org/10.1021/np8002673.
E.B. Russo, Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid
entourage
effects,
Br
J
Pharmacol.
163
(2011)
1344–1364.
https://doi.org/10.1111/j.1476-5381.2011.01238.x.
L. Karila, P. Roux, B. Rolland, A. Benyamina, M. Reynaud, H.-J. Aubin, C. Lancon,
Acute and long-term effects of cannabis use: a review, Curr. Pharm. Des. 20 (2014)
4112–4118.
D.E. Smith, Acute and chronic toxicity of marijuana, J. Psychedelic Drugs. 2 (1968) 37–
48.
K.L. Krishna, M. Paridhavi, J.A. Patel, Review on nutritional, medicinal and
pharmacological properties of Papaya (Carica papaya Linn.), (2008).
T.T. Nguyen, P.N. Shaw, M.O. Parat, A.K. Hewavitharana, Anticancer activity of
Carica papaya: a review, Mol Nutr Food Res. 57 (2013) 153–164.
https://doi.org/10.1002/mnfr.201200388.
M. Naggayi, N. Mukiibi, E. Iliya, The protective effects of aqueous extract of Carica
papaya seeds in paracetamol induced nephrotoxicity in male wistar rats, Afr. Health Sci.
15 (2015) 598–605. https://doi.org/10.4314/ahs.v15i2.37.
V. Anjum, P. Arora, S.H. Ansari, A.K. Najmi, S. Ahmad, Antithrombocytopenic and
immunomodulatory potential of metabolically characterized aqueous extract of Carica
papaya
leaves,
Pharm
Biol.
55
(2017)
2043–2056.
https://doi.org/10.1080/13880209.2017.1346690.
F. Saeed, M.U. Arshad, I. Pasha, R. Naz, R. Batool, A.A. Khan, M.A. Nasir, B. Shafique,
Nutritional and Phyto-Therapeutic Potential of Papaya (Carica papaya Linn.): An
Overview,
Int.
J.
Food
Prop.
17
(2014)
1637–1653.
https://doi.org/10.1080/10942912.2012.709210.
A. Afzan, N.R. Abdullah, S.Z. Halim, B.A. Rashid, R.H.R. Semail, N. Abdullah, I.
Jantan, H. Muhammad, Z. Ismail, Repeated dose 28-days oral toxicity study of Carica
papaya L. leaf extract in Sprague Dawley rats, Molecules. 17 (2012) 4326–4342.
Z. Ismail, S.Z. Halim, N.R. Abdullah, A. Afzan, A. Rashid, B. Amini, I. Jantan, Safety
evaluation of oral toxicity of Carica papaya Linn. leaves: a subchronic toxicity study in
sprague dawley rats, Evidence-Based Complement. Altern. Med. 2014 (2014).
C.W. Choi, S.B. Song, J.S. Oh, Y.H. Kim, Antiproliferation effects of selected Tanzania
plants, African J. Tradit. Complement. Altern. Med. 12 (2015) 96–102.
D.M.W. Anderson, P.C. Bell, The composition of the gum exudates from some
combretum species; the botanical nomenclature and systematics of the combretaceae,
Carbohydr Res. 57 (1977) 215–221. https://doi.org/https://doi.org/10.1016/S00086215(00)81932-1.
M.J. Moshi, D.F. Otieno, P.K. Mbabazi, A. Weisheit, Ethnomedicine of the Kagera
[174]
[175]
[176]
[177]
22
[183]
[184]
[185]
[186]
[187]
[188]
[189]
Jo
[190]
of
[182]
ro
[181]
-p
[180]
re
[179]
ur
na
lP
[178]
Region, north western Tanzania. Part 2: The medicinal plants used in Katoro Ward,
Bukoba District, J. Ethnobiol. Ethnomed. 6 (2010) 19. https://doi.org/10.1186/17464269-6-19.
E. Odongo, N. Mungai, P. Mutai, E. Karumi, J. Mwangi, F. Okalebo, J. Kimondo, J.
Omale, J. Simiyu, Antioxidant and anti-inflammatory activities of selected medicinal
plants from western Kenya, African J. Pharmacol. Ther. 6 (2017).
S.C. Kirui, A.K. Kiprop, F.K. Kiplagat, S.K. Kimno, S.J. Rono, B.K. Kigen, Chemical
assessment and antimicrobial activity of solvent extracts from Kalanchoe densiflora, Int.
J. Educ. Res. 2 (2014) 1–22.
R.H. V Mourão, F.O. Santos, E.M. Franzotti, M.P.N. Moreno, A.R. Antoniolli,
Antiinflammatory activity and acute toxicity (LD50) of the juice of Kalanchoe
brasiliensis (Comb.) leaves picked before and during blooming, Phyther. Res. An Int. J.
Devoted to Pharmacol. Toxicol. Eval. Nat. Prod. Deriv. 13 (1999) 352–354.
F.A. Hamill, S. Apio, N.K. Mubira, M. Mosango, R. Bukenya-Ziraba, O.W. Maganyi,
Traditional herbal drugs of Southern Uganda, J Ethnopharmacol. 70 (2000).
https://doi.org/10.1016/s0378-8741(00)00180-x.
B. Abera, Medicinal plants used in traditional medicine by Oromo people, Ghimbi
District, Southwest Ethiopia, J Ethnobiol Ethnomed. 10 (2014) 40.
https://doi.org/10.1186/1746-4269-10-40.
I.M. Villasen̄or, A.L.O. Bartolome, L.C. Daclan, A.J.G. Manatad, Microbiological and
pharmacological studies on extracts of Cucurbita maxima, Phyther. Res. 9 (1995) 376–
378. https://doi.org/doi:10.1002/ptr.2650090514.
M. Miró, Cucurbitacins and their pharmacological effects, Phyther. Res. 9 (1995) 159–
168. https://doi.org/doi:10.1002/ptr.2650090302.
F.U. Caili, S. Huan, L.I. Quanhong, A review on pharmacological activities and
utilization technologies of pumpkin, Plant Foods Hum. Nutr. 61 (2006) 70–77.
T. Matsuno, Y. Tani, T. Maoka, K. Matsuo, T. Komori, Isolation and structural
elucidation of cucurbitaxanthin a and b from pumpkin Cucurbita maxima,
Phytochemistry. 25 (1986) 2837–2840. https://doi.org/https://doi.org/10.1016/S00319422(00)83753-X.
R.C.B. Cruz, C.D. Meurer, E.J. Silva, C. Schaefer, A.R.S. Santos, A. Bella Cruz, V.
Cechinel Filho, Toxicity Evaluation of Cucurbita maxima. Seed Extract in Mice, Pharm.
Biol. 44 (2006) 301–303.
A. de Queiroz-Neto, M.I. Mataqueiro, A.E. Santana, A.C. Alessi, Toxicologic
evaluation of acute and subacute oral administration of Cucurbita maxima seed extracts
to rats and swine, J. Ethnopharmacol. 43 (1994) 45–51.
O.O. Igbinosa, E.O. Igbinosa, O.A. Aiyegoro, Antimicrobial activity and phytochemical
screening of stem bark extracts from Jatropha curcas (Linn), African J. Pharm.
Pharmacol. 3 (2009) 58–62.
R.K. Devappa, S.K. Rajesh, V. Kumar, H.P. Makkar, K. Becker, Activities of Jatropha
curcas phorbol esters in various bioassays, Ecotoxicol Env. Saf. 78 (2012) 57–62.
https://doi.org/10.1016/j.ecoenv.2011.11.002.
A.M. Mujumdar, A. V Misar, Anti-inflammatory activity of Jatropha curcas roots in
mice and rats, J. Ethnopharmacol. 90 (2004) 11–15.
R.K. Devappa, H.P.S. Makkar, K. Becker, Jatropha Diterpenes: a Review, J. Am. Oil
Chem. Soc. 88 (2011) 301–322. https://doi.org/doi:10.1007/s11746-010-1720-9.
J.-Q. Liu, Y.-F. Yang, C.-F. Wang, Y. Li, M.-H. Qiu, Three new diterpenes from
Jatropha
curcas,
Tetrahedron.
68
(2012)
972–976.
https://doi.org/https://doi.org/10.1016/j.tet.2011.12.006.
M.J. Luo, W.X. Liu, X.Y. Yang, Y. Xu, F. Yan, P. Huang, F. Chen, Cloning, expression,
[191]
[192]
[193]
[194]
23
[200]
[201]
[202]
[203]
[204]
[205]
[206]
Jo
[207]
of
[199]
ro
[198]
-p
[197]
re
[196]
ur
na
lP
[195]
and antitumor activity of recombinant protein of curcin, Russ. J. Plant Physiol. 54 (2007)
202–206. https://doi.org/10.1134/s1021443707020070.
C.-Y. Li, R.K. Devappa, J.-X. Liu, J.-M. Lv, H.P.S. Makkar, K. Becker, Toxicity of
Jatropha curcas phorbol esters in mice, Food Chem. Toxicol. 48 (2010) 620–625.
K.J. Mampane, P.H. Joubert, I.T. Hay, Jatropha curcas: use as a traditional Tswana
medicine and its role as a cause of acute poisoning, Phyther. Res. 1 (1987) 50–51.
P.H. Joubert, J.M. Brown, I.T. Hay, P.D. Sebata, Acute poisoning with Jatropha curcas
(purging nut tree) in children., South African Med. Journal= Suid-Afrikaanse Tydskr.
Vir Geneeskd. 65 (1984) 729–730.
A. Asase, G.A. Akwetey, D.G. Achel, Ethnopharmacological use of herbal remedied for
the treatment of malaria in the Dangne West District of Ghana, J Ethopharmacol. 129
(2010). https://doi.org/10.1016/j.jep.2010.04.001.
F. Sandberg, P. Perera-Ivarsson, H.R. El-Seedi, A Swedish collection of medicinal
plants
from
Cameroon,
J.
Ethnopharmacol.
102
(2005)
336–343.
https://doi.org/http://dx.doi.org/10.1016/j.jep.2005.06.032.
M.M. Iwu, Handbook of African medicinal plants, CRC Press LLC, USA, 1993.
O.O. Adeyemi, O.K. Yemitan, L. Afolabi, Inhibition of chemically induced
inflammation and pain by orally and topically administered leaf extract of Manihot
esculenta Crantz in rodents, J Ethnopharmacol. 119 (2008) 6–11.
https://doi.org/10.1016/j.jep.2008.05.019.
E. Rivadeneyra-Dominguez, A. Vazquez-Luna, J.F. Rodriguez-Landa, R. Diaz-Sobac,
Neurotoxic effect of linamarin in rats associated with cassava (Manihot esculenta
Crantz)
consumption,
Food
Chem
Toxicol.
59
(2013)
230–235.
https://doi.org/10.1016/j.fct.2013.06.004.
Y.-M. Pan, T. Zou, Y.-J. Chen, J.-Y. Chen, X. Ding, Y. Zhang, X.-J. Hao, H.-P. He,
Two new pentacyclic triterpenoids from the stems of Manihot esculenta, Phytochem.
Lett. 12 (2015) 273–276. https://doi.org/https://doi.org/10.1016/j.phytol.2015.04.018.
C. Balagopalan, G. Padmaja, S.K. Nanda, S.N. Moorthy, Cassava in food, feed and
industry CRC Press, Boca Raton, FL, EU. (1988).
V. Kuete, 22 - Physical, Hematological, and Histopathological Signs of Toxicity
Induced by African Medicinal Plants, in: V. Kuete (Ed.), Toxicol. Surv. African Med.
Plants, Elsevier, 2014: pp. 635–657. https://doi.org/https://doi.org/10.1016/B978-0-12800018-2.00022-4.
L.N. Kamau, M.P. Mbaabu, J.M. Mbaria, G.P. Karuri, S.G. Kiama, Knowledge and
demand for medicinal plants used in the treatment and management of diabetes in Nyeri
County,
Kenya,
J.
Ethnopharmacol.
189
(2016)
218–229.
https://doi.org/https://doi.org/10.1016/j.jep.2016.05.021.
I.M.S. Eldeen, J. Van Staden, In vitro pharmacological investigation of extracts from
some trees used in Sudanese traditional medicine, South African J. Bot. 73 (2007) 435–
440. https://doi.org/https://doi.org/10.1016/j.sajb.2007.03.009.
S. Zingue, T. Michel, J. Cisilotto, A.B. Tueche, D.T. Ndinteh, L.J. Mello, D. Njamen,
T.B. Creczynski-Pasa, The hydro-ethanolic extract of Acacia seyal (Mimosaceae) stem
barks induced death in an ER-negative breast cancer cell line by the intrinsic pathway
of apoptosis and inhibited cell migration, J Ethnopharmacol. 223 (2018) 41–50.
https://doi.org/10.1016/j.jep.2018.05.021.
S. Zingue, A.N. Njuh, A.B. Tueche, J. Tamsa, E.N. Tchoupang, S.D. Kakene, M.T.K.
Sipping, D. Njamen, In Vitro Cytotoxicity and In vivo Antimammary tumor effects of
the hydroethanolic extract of Acacia seyal (Mimosaceae) Stem Bark, Biomed Res Int.
2018 (2018) 2024602. https://doi.org/10.1155/2018/2024602.
B. Bi, H. Yang, Y. Fang, K. Nishinari, G.O. Phillips, Characterization and emulsifying
[208]
[209]
[210]
24
[213]
[214]
[215]
[218]
[219]
[220]
Jo
[221]
ur
na
lP
[217]
re
-p
[216]
of
[212]
ro
[211]
properties of beta-lactoglobulin-gum Acacia Seyal conjugates prepared via the Maillard
reaction,
Food
Chem.
214
(2017)
614–621.
https://doi.org/10.1016/j.foodchem.2016.07.112.
M.H.A. Suleiman, An ethnobotanical survey of medicinal plants used by communities
of Northern Kordofan region, Sudan, J. Ethnopharmacol. 176 (2015) 232–242.
https://doi.org/https://doi.org/10.1016/j.jep.2015.10.039.
E.V.M. Kigondu, G.M. Rukunga, J.M. Keriko, W.K. Tonui, J.W. Gathirwa, P.G. Kirira,
B. Irungu, J.M. Ingonga, I.O. Ndiege, Anti-parasitic activity and cytotoxicity of selected
medicinal plants from Kenya, J. Ethnopharmacol. 123 (2009) 504–509.
https://doi.org/http://dx.doi.org/10.1016/j.jep.2009.02.008.
O.P. Note, A.C. Mitaine-Offer, T. Miyamoto, T. Paululat, J.F. Mirjolet, O. Duchamp,
D.E. Pegnyemb, M.A. Lacaille-Dubois, Cytotoxic acacic acid glycosides from the roots
of
Albizia
coriaria,
J
Nat
Prod.
72
(2009)
1725–1730.
https://doi.org/10.1021/np900126r.
R. Byamukama, B. Ganza, J. Namukobe, M. Heydenreich, B. Kiremire, Bioactive
compounds in the stem bark of Albizia coriaria (Welw. ex Oliver), Int. J. Biol. Chem.
Sci. 9 (2015) 1013. https://doi.org/10.4314/ijbcs.v9i2.37.
C.J. Botha, M.L. Penrith, Poisonous plants of veterinary and human importance in
southern
Africa,
J.
Ethnopharmacol.
119
(2008)
549–558.
https://doi.org/https://doi.org/10.1016/j.jep.2008.07.022.
H.R. Randrianarivo, A.R. Razafindrakoto, H.C. Ratsimanohatra, L.J.
Randriamampianina,
C.F.
Rajemiarimoelisoa,
L.
Ramamonjisoa,
D.
Ramanitrahasimbola, D.A.D. Rakoto, V.L. Jeannoda, Toxic effects of seed methanolic
extracts of endemic Albizia species (Fabaceae) from Madagascar on animals, J. Life Sci.
8 (2014).
H.P. Nguyen, J. Hanson, D. Bethell, T.H. Nguyen, T.H. Tran, V.C. Ly, A retrospective
analysis of the haemodynamic and metabolic effects of fluid resuscitation in Vietnamese
adults with severe falciparum malaria, PLoS One. 6 (2011).
D. Lacroix, S. Prado, D. Kamoga, J. Kasenene, J. Namukobe, S. Krief, V. Dumontet, E.
Mouray, B. Bodo, F. Brunois, Antiplasmodial and cytotoxic activities of medicinal
plants traditionally used in the village of Kiohima, Uganda, J. Ethnopharmacol. 133
(2011) 850–855. https://doi.org/http://dx.doi.org/10.1016/j.jep.2010.11.013.
A. Yenesew, M. Induli, S. Derese, J.O. Midiwo, M. Heyden, G.M. Peter, Waters NC:
Anti-plasmodia flavonoids from the stem of Erythrina abyssinica, Phytochemistry. 65
(2004). https://doi.org/10.1016/j.phytochem.2004.08.050.
G.N. Teke, P.K. Lunga, H.K. Wabo, J.-R. Kuiate, G. Vilarem, G. Giacinti, H. Kikuchi,
Y. Oshima, Antimicrobial and antioxidant properties of methanol extract, fractions and
compounds from the stem bark of Entada abyssinica Stend ex A. Satabie, BMC
Complement Altern Med. 11 (2011) 57. https://doi.org/10.1186/1472-6882-11-57.
F. Freiburghaus, A. Steck, H. Pfander, R. Brun, Bioassay-guided isolation of a
diastereoisomer of kolavenol from Entada abyssinica active on Trypanosoma brucei
rhodesiense,
J.
Ethnopharmacol.
61
(1998)
179–183.
https://doi.org/http://dx.doi.org/10.1016/S0378-8741(98)00035-X.
O.A. Olajide, A.R.A. Alada, Studies on the anti-inflammatory properties of Entada
abyssinica,
Fitoterapia.
72
(2001)
492–496.
https://doi.org/https://doi.org/10.1016/S0367-326X(01)00273-8.
E.E. Haule, M.J. Moshi, R.S.O. Nondo, D.T. Mwangomo, R.L.A. Mahunnah, A study
of antimicrobial activity, acute toxicity and cytoprotective effect of a polyherbal extract
in a rat ethanol-HCl gastric ulcer model, BMC Res. Notes. 5 (2012) 546.
S.N. Rai, H. Birla, W. Zahra, S. Sen Singh, S.P. Singh, Immunomodulation of
[222]
[223]
[224]
25
Jo
ur
na
lP
re
-p
ro
of
Parkinson’s disease using Mucuna pruriens (Mp), J. Chem. Neuroanat. 85 (2017) 27–
35. https://doi.org/https://doi.org/10.1016/j.jchemneu.2017.06.005.
[225] M.B. Obogwu, A.J. Akindele, O.O. Adeyemi, Hepatoprotective and in vivo antioxidant
activities of the hydroethanolic leaf extract of Mucuna pruriens (Fabaceae) in
antitubercular drugs and alcohol models, Chin. J. Nat. Med. 12 (2014) 273–283.
https://doi.org/https://doi.org/10.1016/S1875-5364(14)60054-6.
[226] L. Misra, H. Wagner, Alkaloidal constituents of Mucuna pruriens seeds, Phytochemistry.
65 (2004) 2565–2567. https://doi.org/https://doi.org/10.1016/j.phytochem.2004.08.045.
[227] N. Duangnin, T. Phitak, P. Pothacharoen, P. Kongtawelert, In vitro and in vivo
investigation of natural compounds from seed extract of Mucuna pruriens lacking lDOPA for the treatment of erectile dysfunction, Asian Pac J Trop Med. 10 (2017) 238–
252. https://doi.org/10.1016/j.apjtm.2017.03.001.
[228] S. Suresh, E. Prithiviraj, S. Prakash, Dose- and time-dependent effects of ethanolic
extract of Mucuna pruriens Linn. seed on sexual behaviour of normal male rats, J.
Ethnopharmacol.
122
(2009)
497–501.
https://doi.org/https://doi.org/10.1016/j.jep.2009.01.032.
[229] S. Golbabapour, M. Hajrezaie, P. Hassandarvish, N. Abdul Majid, A.H.A. Hadi, N.
Nordin, M.A. Abdulla, Acute toxicity and gastroprotective role of M. pruriens in
ethanol-induced gastric mucosal injuries in rats, Biomed Res. Int. 2013 (2013).
[230] A. Abbott, Levodopa: the story so far, Nature. 466 (2010) S6-7.
https://doi.org/10.1038/466S6a.
[231] F.S. Paula, L.M. Kabeya, A. Kanashiro, A.S. de Figueiredo, A.E. Azzolini, S.A.
Uyemura, Y.M. Lucisano-Valim, Modulation of human neutrophil oxidative
metabolism and degranulation by extract of Tamarindus indica L. fruit pulp, Food Chem
Toxicol. 47 (2009) 163–170. https://doi.org/10.1016/j.fct.2008.10.023.
[232] T.T. Sreelekha, T. Vijayakumar, R. Ankanthil, K.K. Vijayan, M.K. Nair,
Immunomodulatory effects of a polysaccharide from Tamarindus indica, Anticancer
Drugs. 4 (1993) 209–212.
[233] F. Martinello, V. Kannen, J.J. Franco, B. Gasparotto, J.Y. Sakita, A. Sugohara, S.B.
Garcia, S.A. Uyemura, Chemopreventive effects of a Tamarindus indica fruit extract
against colon carcinogenesis depends on the dietary cholesterol levels in hamsters, Food
Chem Toxicol. 107 (2017) 261–269. https://doi.org/10.1016/j.fct.2017.07.005.
[234] S.S. Bhadoriya, V. Mishra, S. Raut, A. Ganeshpurkar, S.K. Jain, Anti-Inflammatory and
Antinociceptive Activities of a Hydroethanolic Extract of Tamarindus indica Leaves,
Sci Pharm. 80 (2012) 685–700. https://doi.org/10.3797/scipharm.1110-09.
[235] F. Martinello, S.M. Soares, J.J. Franco, A.C. dos Santos, A. Sugohara, S.B. Garcia, C.
Curti, S.A. Uyemura, Hypolipemic and antioxidant activities from Tamarindus indica
L. pulp fruit extract in hypercholesterolemic hamsters, Food Chem. Toxicol. 44 (2006)
810–818.
[236] A. Agnihotri, V. Singh, Effect of Tamarindus indica Linn. and Cassia fistula Linn. stem
bark extracts on oxidative stress and diabetic conditions, Acta Pol Pharm. 70 (2013)
1011–1019.
[237] J.R.S. Tabuti, V.B. Muwanika, M.Z. Arinaitwe, T. Ticktin, Conservation of priority
woody species on farmlands: A case study from Nawaikoke sub-county, Uganda, Appl.
Geogr.
31
(2011)
456–462.
https://doi.org/http://dx.doi.org/10.1016/j.apgeog.2010.10.006.
[238] R.M. Havinga, A. Hartl, J. Putscher, S. Prehsler, C. Buchmann, C.R. Vogl, Tamarindus
indica L. (Fabaceae): Patterns of use in traditional African medicine, J. Ethnopharmacol.
127 (2010) 573–588. https://doi.org/https://doi.org/10.1016/j.jep.2009.11.028.
[239] G. Anywar, H. Oryem-Origa, M. Kamatenesi Mugisha, Wild plants used as
26
[245]
[246]
[247]
[248]
[249]
Jo
[250]
of
[244]
ro
[243]
-p
[242]
re
[241]
ur
na
lP
[240]
nutraceuticals from Nebbi district, Uganda, (2014).
B.O. Owuor, J.O. Ochanda, J.O. Kokwaro, A.C. Cheruiyot, R.A. Yeda, C.A. Okudo,
H.M. Akala, In vitro antiplasmodial activity of selected Luo and Kuria medicinal plants,
J.
Ethnopharmacol.
144
(2012)
779–781.
https://doi.org/http://dx.doi.org/10.1016/j.jep.2012.09.045.
O.D. Otieno, O.B. Awuor, W.G. Wafula, Quality Evaluation of Oil from Seeds of Wild
Plant Tylosema fassoglensis in Kenya, J. Food Process. 2015 (2015) 4.
https://doi.org/10.1155/2015/971871.
M. Holse, S. Husted, Å. Hansen, Chemical composition of marama bean (Tylosema
esculentum)—A wild African bean with unexploited potential, J. Food Compos. Anal.
23 (2010) 648–657. https://doi.org/https://doi.org/10.1016/j.jfca.2010.03.006.
C. Agyare, A. Asase, M. Lechtenberg, M. Niehues, A. Deters, A. Hensel, An
ethnopharmacological survey and in vitro confirmation of ethnopharmacological use of
medicinal plants used for wound healing in Bosomtwi-Atwima-Kwanwoma area, Ghana,
J.
Ethnopharmacol.
125
(2009)
393–403.
https://doi.org/http://dx.doi.org/10.1016/j.jep.2009.07.024.
B.T. Ngadjui, J.F. Ayafor, B.L. Sondengam, J.D. Connolly, D.S. Rycroft, Hoslundin,
hoslundal, and hoslunddiol: three new flavonoids from the twigs of Hoslundia opposita
(lamiaceae),
Tetrahedron.
47
(1991)
3555–3564.
https://doi.org/http://dx.doi.org/10.1016/S0040-4020(01)80869-3.
B.T. Ngadjui, J.F. Ayafor, B.L. Sondengam, J.D. Connolly, D.S. Rycroft, F. Tillequin,
Oppositin and 5-O-methylhoslundin, pyrone-substituted flavonoids of Hoslundia
opposita,
Phytochemistry.
32
(1993)
1313–1315.
https://doi.org/http://dx.doi.org/10.1016/S0031-9422(00)95112-4.
R. Salame, Z. Cheikh-Ali, C. Bories, M. Adiko, E. Poupon, P. Champy, Pyrone and
Unusually Furanone-substituted Flavones from the Leaves of Hoslundia opposita,
Planta Med. 78 (2012) 1777–1779.
C.K. Murithi, D.S. Fidahusein, J.M. Nguta, C.W. Lukhoba, Antimalarial activity and in
vivo toxicity of selected medicinal plants naturalised in Kenya, Int J Edu Res. 2 (2014)
395–406.
F. Ocheng, F. Bwanga, M. Joloba, A. Softrata, M. Azeem, xfc, K. tsep, A.-K. BorgKarlson, C. Obua, A. Gustafsson, Essential oils from Ugandan aromatic medicinal
plants: Chemical composition and growth inhibitory effects on oral pathogens,
Evidence-Based
Complement.
Altern.
Med.
2015
(2015)
10.
https://doi.org/10.1155/2015/230832.
A. Kumar, R. Gupta, R.K. Mishra, A.C. Shukla, A. Dikshit, Pharmaco-phylogenetic
investigation of Micromeria biflora Benth and Citrus reticulata Blanco, Natl. Acad. Sci.
Lett. 35 (2012) 253–257.
M. Chandra, P. Om, R.K. Bachheti, M. Kumar, A.K. Pant, Essential oil composition and
pharmacological activities of Micromeria biflora (Buch.-Ham. Ex D. Don) Benth.
collected from Uttarakhand region of India, J. Med. Plants Res. 4 (2013) 2538–2544.
M.A. Khan, M.A. Khan, M. Hussain, G.M. Ghulam, An ethnobotanical inventory of
himalayan region poonch valley azad kashmir (Pakistan), Ethnobot. Res. Appl. 8 (2010)
107–123.
F.T. Yamassaki, L.H. Campestrini, S.F. Zawadzki-Baggio, J.B.B. Maurer, Chemical
characterization and complement modulating activities of an arabinogalactan-proteinrich fraction from an aqueous extract of avocado leaves, Int J Biol Macromol. 120 (2018)
513–521. https://doi.org/10.1016/j.ijbiomac.2018.08.072.
O.O. Adeyemi, S.O. Okpo, O.O. Ogunti, Analgesic and anti-inflammatory effects of the
aqueous extract of leaves of Persea americana mill (lauraceae), Fitoterapia. 73 (2002)
[251]
[252]
[253]
27
Jo
ur
na
lP
re
-p
ro
of
375–380.
[254] I. Castillo-Juarez, V. Gonzalez, H. Jaime-Aguilar, G. Martinez, E. Linares, R. Bye, I.
Romero, Anti-Helicobacter pylori activity of plants used in Mexican traditional
medicine for gastrointestinal disorders, J Ethnopharmacol. 122 (2009) 402–405.
https://doi.org/10.1016/j.jep.2008.12.021.
[255] A.T. Mbaveng, H.T. Manekeng, G.S. Nguenang, J.K. Dzotam, V. Kuete, T. Efferth,
Cytotoxicity of 18 Cameroonian medicinal plants against drug sensitive and multifactorial drug resistant cancer cells, J. Ethnopharmacol. 222 (2018) 21–33.
https://doi.org/https://doi.org/10.1016/j.jep.2018.04.036.
[256] M.A. Owolabi, H.A.B. Coker, S.I. Jaja, Bioactivity of the phytoconstituents of the leaves
of Persea americana, J. Med. Plants Res. 4 (2010) 1130–1135.
[257] R.I. Ozolua, O.N. Anaka, S.O. Okpo, S.E. Idogun, Acute and sub-acute toxicological
assessment of the aqueous seed extract of Persea americana Mill (Lauraceae) in rats,
Afr J Tradit Complement Altern Med. 6 (2009).
[258] E. Padilla-Camberos, M. Martínez-Velázquez, J.M. Flores-Fernández, S. VillanuevaRodríguez, Acute toxicity and genotoxic activity of avocado seed extract (Persea
americana Mill., cv Hass), Sci. World J. 2013 (2013).
[259] J.R. Tabuti, C.B. Kukunda, P.J. Waako, Medicinal plants used by traditional medicine
practitioners in the treatment of tuberculosis and related ailments in Uganda, J
Ethnopharmacol. 127 (2010) 130–136. https://doi.org/10.1016/j.jep.2009.09.035.
[260] M. Haidari, M. Ali, S. Ward Casscells 3rd, M. Madjid, Pomegranate (Punica granatum)
purified polyphenol extract inhibits influenza virus and has a synergistic effect with
oseltamivir,
Phytomedicine.
16
(2009)
1127–1136.
https://doi.org/10.1016/j.phymed.2009.06.002.
[261] N.S. Al-Zoreky, Antimicrobial activity of pomegranate (Punica granatum L.) fruit peels,
Int
J
Food
Microbiol.
134
(2009)
244–248.
https://doi.org/10.1016/j.ijfoodmicro.2009.07.002.
[262] E.P. Lansky, R.A. Newman, Punica granatum (pomegranate) and its potential for
prevention and treatment of inflammation and cancer, J Ethnopharmacol. 109 (2007)
177–206. https://doi.org/10.1016/j.jep.2006.09.006.
[263] S. Rout, R. Banerjee, Free radical scavenging, anti-glycation and tyrosinase inhibition
properties of a polysaccharide fraction isolated from the rind from Punica granatum,
Bioresour.
Technol.
98
(2007)
3159–3163.
https://doi.org/https://doi.org/10.1016/j.biortech.2006.10.011.
[264] S. Madrigal-Carballo, G. Rodriguez, C.G. Krueger, M. Dreher, J.D. Reed, Pomegranate
(Punica granatum) supplements: Authenticity, antioxidant and polyphenol composition,
J.
Funct.
Foods.
1
(2009)
324–329.
https://doi.org/https://doi.org/10.1016/j.jff.2009.02.005.
[265] A. Vidal, A. Fallarero, B.R. Peña, M.E. Medina, B. Gra, F. Rivera, Y. Gutierrez, P.M.
Vuorela, Studies on the toxicity of Punica granatum L.(Punicaceae) whole fruit extracts,
J. Ethnopharmacol. 89 (2003) 295–300.
[266] L.C. Braga, J.W. Shupp, C. Cummings, M. Jett, J.A. Takahashi, L.S. Carmo, E.
Chartone-Souza, A.M. Nascimento, Pomegranate extract inhibits Staphylococcus
aureus growth and subsequent enterotoxin production, J Ethnopharmacol. 96 (2005)
335–339. https://doi.org/10.1016/j.jep.2004.08.034.
[267] M.M. Cowan, Plant products as antimicrobial agents, Clin Microbiol Rev. 12 (1999)
564–582.
[268] S.O. Udegbunam, T.O. Nnaji, R.I. Udegbunam, J.C. Okafor, I. Agbo, Evaluation of
herbal ointment formulation of Milicia excelsa (Welw) CC berg for wound healing,
African J. Biotechnol. 12 (2013).
28
Jo
ur
na
lP
re
-p
ro
of
[269] J.L. Ouete, L.P. Sandjo, D.W. Kapche, J.C. Liermann, T. Opatz, I.K. Simo, B.T. Ngadjui,
A new flavone from the roots of Milicia excelsa (Moraceae), Z Naturforsch C. 68 (2013)
259–263.
[270] J.O. Areola, N.O. Omisore, O.O. Babalola, Antiplasmodial activity of stem-bark extract
of Milicia excelsa (welw.) Cc berg against rodent malaria parasites (Plasmodium
berghei) in mice, Ife J. Sci. 18 (2016) 905–911.
[271] L.A. Akinpelu, M.A. Akanmu, E.M. Obuotor, Antipsychotic effects of ethanol leaf
extract and fractions of Milicia excelsa (Moraceae) in mice, J. Pharm. Res. Int. (2018)
1–10.
[272] J. Nfambi, G.S. Bbosa, L.F. Sembajwe, J. Gakunga, J.N. Kasolo, Immunomodulatory
activity of methanolic leaf extract of Moringa oleifera in Wistar albino rats, J Basic Clin
Physiol Pharmacol. 26 (2015) 603–611. https://doi.org/10.1515/jbcpp-2014-0104.
[273] J.K. Dzotam, F.K. Touani, V. Kuete, Antibacterial and antibiotic-modifying activities
of three food plants (Xanthosoma mafaffa Lam., Moringa oleifera (L.) Schott and
Passiflora edulis Sims) against multidrug-resistant (MDR) Gram-negative bacteria,
BMC Complement Altern Med. 16 (2016). https://doi.org/10.1186/s12906-016-0990-7.
[274] G.A. Asare, B. Gyan, K. Bugyei, S. Adjei, R. Mahama, P. Addo, L. Otu-Nyarko, E.K.
Wiredu, A. Nyarko, Toxicity potentials of the nutraceutical Moringa oleifera at suprasupplementation levels, J. Ethnopharmacol. 139 (2012) 265–272.
[275] O. Awodele, I.A. Oreagba, S. Odoma, J.A.T. da Silva, V.O. Osunkalu, Toxicological
evaluation of the aqueous leaf extract of Moringa oleifera Lam.(Moringaceae), J.
Ethnopharmacol. 139 (2012) 330–336.
[276] J.N. Kasolo, G.S. Bimenya, L. Ojok, J.W. Ogwal-Okeng, Phytochemicals and acute
toxicity of Moringa oleifera roots in mice, J. Pharmacogn. Phyther. 3 (2011) 38–42.
[277] J.O. Popoola, O.O. Obembe, Local knowledge, use pattern and geographical distribution
of Moringa oleifera Lam. (Moringaceae) in Nigeria, J. Ethnopharmacol. 150 (2013)
682–691. https://doi.org/https://doi.org/10.1016/j.jep.2013.09.043.
[278] X.-J. Qin, Q. Yu, H. Yan, A. Khan, M.-Y. Feng, P.-P. Li, X.-J. Hao, L.-K. An, H.-Y.
Liu, Meroterpenoids with Antitumor Activities from Guava (Psidium guajava), J. Agric.
Food Chem. 65 (2017) 4993–4999. https://doi.org/10.1021/acs.jafc.7b01762.
[279] M.A. Bisi-Johnson, C.L. Obi, B.B. Samuel, J.N. Eloff, A.I. Okoh, Antibacterial activity
of crude extracts of some South African medicinal plants against multidrug resistant
etiological agents of diarrhoea, BMC Complement Altern Med. 17 (2017) 321.
https://doi.org/10.1186/s12906-017-1802-4.
[280] M. Jang, S.W. Jeong, S.K. Cho, K.S. Ahn, J.H. Lee, D.C. Yang, J.C. Kim, Antiinflammatory effects of an ethanolic extract of guava (Psidium guajava L.) leaves in
vitro
and
in
vivo,
J
Med
Food.
17
(2014)
678–685.
https://doi.org/10.1089/jmf.2013.2936.
[281] M. David, T.J. Abraham, T.S. Nagesh, H. Adikesavalu, Immunomodulatory effect of
Guavarine®, aqueous guava leaf extract, on ornamental Koi carp Cyprinus carpio var.
koi
L.
1758,
J.
Appl.
Aquac.
29
(2017)
322–330.
https://doi.org/10.1080/10454438.2017.1363680.
[282] P. Jaiarj, P. Khoohaswan, Y. Wongkrajang, P. Peungvicha, P. Suriyawong, M.L.S.
Saraya, O. Ruangsomboon, Anticough and antimicrobial activities of Psidium guajava
Linn. leaf extract, J. Ethnopharmacol. 67 (1999) 203–212.
[283] S. Kannan, B.P. Devi, B. Jayakar, Antibacterial evaluation of the methanolic extract of
Passiflora edulis, (2011).
[284] Y.J. Zhang, T. Zhou, F. Wang, Y. Zhou, Y. Li, J.J. Zhang, J. Zheng, D.P. Xu, H.B. Li,
The Effects of Syzygium samarangense, Passiflora edulis and Solanum muricatum on
Alcohol-Induced
Liver
Injury,
Int
J
Mol
Sci.
17
(2016).
29
[290]
[291]
[292]
[293]
[294]
[295]
Jo
[296]
of
[289]
ro
[288]
-p
[287]
re
[286]
ur
na
lP
[285]
https://doi.org/10.3390/ijms17101616.
V. Kuete, J.K. Dzotam, I.K. Voukeng, A.G. Fankam, T. Efferth, Cytotoxicity of
methanol extracts of Annona muricata, Passiflora edulis and nine other Cameroonian
medicinal plants towards multi-factorial drug-resistant cancer cell lines, Springerplus. 5
(2016). https://doi.org/10.1186/s40064-016-3361-4.
T. Ichimura, A. Yamanaka, T. Ichiba, T. Toyokawa, Y. Kamada, T. Tamamura, S.
Maruyama, Antihypertensive effect of an extract of Passiflora edulis rind in
spontaneously hypertensive rats, Biosci Biotechnol Biochem. 70 (2006) 718–721.
https://doi.org/10.1271/bbb.70.718.
K. Devaki, U. Beulah, G. Akila, V.K. Gopalakrishnan, Effect of aqueous extract of
Passiflora edulis on biochemical and hematological parameters of Wistar albino rats,
Toxicol. Int. 19 (2012) 63.
E. Maluf, H.M.T. Barros, M.L. Frochtengarten, R. Benti, J.R. Leite, Assessment of the
hypnotic/sedative effects and toxicity of Passiflora edulis aqueous extract in rodents and
humans, Phyther. Res. 5 (1991) 262–266.
P.O. Bessong, C.L. Obi, M.L. Andréola, L.B. Rojas, L. Pouysegu, E. Igumbor, J.J.M.
Meyer, S. Quideau, S. Litvak, Evaluation of selected South African medicinal plants for
inhibitory properties against human immunodeficiency virus type 1 reverse transcriptase
and integrase, J Ethnopharmacol. 99 (2005). https://doi.org/10.1016/j.jep.2005.01.056.
T.A. Ngueyem, G. Brusotti, G. Caccialanza, P.V. Finzi, The genus Bridelia: A
phytochemical and ethnopharmacological review, J. Ethnopharmacol. 124 (2009) 339–
349. https://doi.org/http://dx.doi.org/10.1016/j.jep.2009.05.019.
K.H. Pegel, C.B. Rogers, Mollic acid 3-β-d-glucoside, a novel 1α-hydroxycycloartane
saponin from Combretum molle (combretaceae), Tetrahedron Lett. 17 (1976) 4299–
4302. https://doi.org/http://dx.doi.org/10.1016/0040-4039(76)80100-1.
B.I. Okeleye, P.O. Bessong, R.N. Ndip, Preliminary phytochemical screening and in
vitro anti-Helicobacter pylori activity of extracts of the stem bark of Bridelia micrantha
(Hochst., Baill., Euphorbiaceae), Molecules. 16 (2011) 6193–6205.
M.J. Moshi, E. Innocent, J.J. Magadula, D.F. Otieno, A. Weisheit, P.K. Mbabazi, R.S.O.
Nondo, Brine shrimp toxicity of some plants used as traditional medicines in Kagera
region, north western Tanzania, Tanzan. J. Health Res. 12 (2010) 63–67.
S.O. Onoja, C.O. Ukwueze, M.I. Ezeja, N. Udeh, Antinociceptive and antioxidant
effects of hydromethanolic extract of Bridelia micrantha stem bark, J. Exp. Integr. Med.
4 (2014) 273.
D.O. Ochwang’i, C.N. Kimwele, J.A. Oduma, P.K. Gathumbi, S.G. Kiama, T. Efferth,
Cytotoxic activity of medicinal plants of the Kakamega County (Kenya) against drugsensitive and multidrug-resistant cancer cells, J. Ethnopharmacol. 215 (2018) 233–240.
https://doi.org/https://doi.org/10.1016/j.jep.2018.01.004.
A.J. Al-Rehaily, M. Yousaf, M.S. Ahmad, V. Samoylenko, X.-C. Li, I. Muhammad,
K.E.H. El Tahir, Chemical and biological study of Flueggea virosa native to Saudi
Arabia, Chem. Nat. Compd. 51 (2015) 187–188.
J.O.C. Ezeonwumelu, A.N. Omar, A.M. Ajayi, A.G. Okoruwa, J.K. Tanayen, D.M.
Kiplagat, O.A. Okpanachi, S. Abba, I. Ezekiel, A.N. Onchweri, Phytochemical
screening, acute toxicity, anti-inflammatory and antipyretic studies of aqueous extract
of the root of Flueggea virosa (Roxb. ex Willd.) in rats, Int. J. Pharm. Biomed. Sci. 3
(2012) 128.
L. Tona, K. Kambu, N. Ngimbi, K. Cimanga, A.J. Vlietinck, Antiamoebic and
phytochemical screening of some Congolese medicinal plants, J Ethnopharmacol. 61
(1998) 57–65.
A. Mann, J.O. Amupitan, A.O. Oyewale, J.I. Okogun, K. Ibrahim, P. Oladosu, L.
[297]
[298]
[299]
30
[305]
[306]
[307]
[308]
[309]
[310]
Jo
[311]
of
[304]
ro
[303]
-p
[302]
re
[301]
ur
na
lP
[300]
Lawson, I. Olajide, A. Nnamdi, Evaluation of in vitro antimycobacterial activity of
Nigerian plants used for treatment of respiratory diseases, African J. Biotechnol. 7
(2008).
M.O. Sofidiya, O.A. Odukoya, A.A. Adedapo, H.O.C. Mbagwu, A.J. Afolayan, O.B.
Familoni, Investigation of the anti-inflammatory and antinociceptive activities of
Hymenocardia acida Tul. (Hymenocardiaceae), African J. Biotechnol. 9 (2010) 8454–
8459.
E. Tuenter, K. Segers, K. Kang, J. Viaene, S. Sung, P. Cos, L. Maes, Y. Heyden, L.
Pieters, Antiplasmodial activity, cytotoxicity and structure-activity relationship study of
cyclopeptide alkaloids, Molecules. 22 (2017) 224.
O.J. Igoli, I.A. Gray, Friedelanone and other triterpenoids from Hymenocardia acida,
Int. J. Phys. Sci. 3 (2008) 156–158.
A.A. Sowemimo, F.A. Fakoya, I. Awopetu, O.R. Omobuwajo, S.A. Adesanya, Toxicity
and mutagenic activity of some selected Nigerian plants, J. Ethnopharmacol. 113 (2007)
427–432.
A.I. Alli, J.O. Ehinmidu, Y.K. Ibrahim, Evaluation Of Antmicrobial Properties, Acute
Toxicity and Immunostimulatory Potential of Phyllanthus amarus, Niger. J. Chem. Res.
16 (2011) 1–8.
L. Van Puyvelde, I. Geiser, P.-C. Rwangabo, B. Sebikali, Rwandese herbal remedies
used
against
gonorrhoea,
J.
Ethnopharmacol.
8
(1983)
279–286.
https://doi.org/https://doi.org/10.1016/0378-8741(83)90065-X.
H. Süleyman, L.Ö. Demirezer, A. Kuruüzüm, Z.N. Banoğlu, F. Göçer, G. Özbakir, A.
Gepdiremen, Antiinflammatory effect of the aqueous extract from Rumex patientia L.
roots, J. Ethnopharmacol. 65 (1999) 141–148.
C. Schlage, C. Mabula, R.L.A. Mahunnah, M. Heinrich, Medicinal plants of the
Washambaa (Tanzania): documentation andethnopharmacalogical evaluation, Plant
Biol. 2 (2000). https://doi.org/10.1055/s-2000-296.
N.I. Mongalo, L.J. McGaw, J.F. Finnie, J. Van Staden, Securidaca longipedunculata
Fresen (Polygalaceae): A review of its ethnomedicinal uses, phytochemistry,
pharmacological properties and toxicology, J. Ethnopharmacol. 165 (2015) 215–226.
https://doi.org/http://dx.doi.org/10.1016/j.jep.2015.02.041.
C.O. Okoli, P.A. Akah, U. Ezugworie, Anti-inflammatory activity of extracts of root
bark of Securidaca longipedunculata Fres (Polygalaceae), African J. Tradit.
Complement. Altern. Med. 3 (2006) 54–63.
X. Luo, D. Pires, J.A. Ainsa, B. Gracia, S. Mulhovo, A. Duarte, E. Anes, M.J. Ferreira,
Antimycobacterial evaluation and preliminary phytochemical investigation of selected
medicinal plants traditionally used in Mozambique, J Ethnopharmacol. 137 (2011) 114–
120. https://doi.org/10.1016/j.jep.2011.04.062.
L. Apak, D. Olila, The in-vitro antibacterial activity of Annona senegalensis,
Securidacca longipendiculata and Steganotaenia araliacea - Ugandan medicinal plants,
Afr Heal. Sci. 6 (2006) 31–35. https://doi.org/10.5555/afhs.2006.6.1.31.
J.M. Watt, M.G. Breyer-Brandwijk, No Title, in: Med. Poisonous Plants South. East.
Africa, S. Livingstone Ltd., Edinburgh and London, 1962.
S.A. Junaid, A. Abubakar, A.C. Ofodile, A.O. Olabode, G.O.N. Echeonwu, A.E.J.
Okwori, J.A. Adetunji, Evaluation of Securidaca longipenduculata leaf and root extracts
for antimicrobial activities, African J. Microbiol. Res. 2 (2008) 322–325.
A. Meli Lannang, D. Lontsi, F.N. Ngounou, B.L. Sondengam, A.E. Nkengfack, F.R.
van Heerden, J.C.N. Assob, Securidacaxanthone A, a heptaoxygenated xanthone from
Securidaca
longepedunculata,
Fitoterapia.
77
(2006)
199–202.
https://doi.org/http://dx.doi.org/10.1016/j.fitote.2006.01.006.
[312]
[313]
[314]
31
Jo
ur
na
lP
re
-p
ro
of
[315] J. Moshi, Z.H. Mbwambo, R.S.O. Nondo, P.J. Masimba, A. Kamuhabwa, M.C. Kapingu,
P. Thomas, M. Richard, Evaluation of ethnomedical claims and Brine shrimp toxicity
of some plants used in Tanzania as Traditional medicines, African J. Tradit.
Complement. Altern. Med. 3 (2006). https://doi.org/10.4314/ajtcam.v3i3.31166.
[316] R.C. Adiele, B.B. Fakae, I.U. Isuzu, Anthelmintic activity of Securidaca
longepedunculata (Family: Polygalaceae) root extract in mice, in vitro and in vivo,
Asian
Pac.
J.
Trop.
Med.
6
(2013)
841–846.
https://doi.org/http://dx.doi.org/10.1016/S1995-7645(13)60150-9.
[317] V.A. Luyckx, Nephrotoxicity of alternative medicine practice, Adv Chronic Kidney Dis.
19 (2012) 129–141. https://doi.org/10.1053/j.ackd.2012.04.005.
[318] O.O. Adeyemi, A.J. Akindele, O.K. Yemitan, F.R. Aigbe, F.I. Fagbo, Anticonvulsant,
anxiolytic and sedative activities of the aqueous root extract of Securidaca
longepedunculata
Fresen,
J.
Ethnopharmacol.
130
(2010)
191–195.
https://doi.org/http://dx.doi.org/10.1016/j.jep.2010.04.028.
[319] A. Maroyi, Traditional use of medicinal plants in South Central Zimbabwe: review &
perspectives, J Ethnobiol Ethnomed. 9 (2013). https://doi.org/10.1186/1746-4269-9-31.
[320] T. Stangeland, H. Wangensteen, E. Katuura, K.A. Lye, B.S. Paulsen, Antioxidant and
anti-plasmodial activity of extracts from three Ugandan medicinal plants, J. Med. Plants
Res. 4 (2010) 1916–1923.
[321] M.S. Traore, M.A. Balde, M.S. Diallo, E.S. Balde, S. Diane, A. Camara, A. Diallo, A.
Balde, A. Keita, S.M. Keita, K. Oulare, F.B. Magassouba, I. Diakite, A. Diallo, L.
Pieters, A.M. Balde, Ethnobotanical survey on medicinal plants used by Guinean
traditional healers in the treatment of malaria, J Ethnopharmacol. 150 (2013) 1145–1153.
https://doi.org/10.1016/j.jep.2013.10.048.
[322] H.M. Farah, H.E. Khalid, A.M. El Hussein, H.M. Osman, Toxic effect of Gardenia
ternifolia Fruit on Rats, European J. Med. Plants. (2018) 1–9.
[323] D.G. Fowler, Traditional fever remedies: a list of Zambian plants, Http//Www. Gift.
Org/Ritam/News/Traditional_Fever_remedies 1. Pdf). Accessed April. 20 (2006) 2010.
[324] S. Basu, A. Ghosh, B. Hazra, Evaluation of the antibacterial activity of Ventilago
madraspatana Gaertn., Rubia cordifolia Linn. and Lantana camara Linn.: isolation of
emodin and physcion as active antibacterial agents, Phyther. Res. 19 (2005) 888–894.
https://doi.org/doi:10.1002/ptr.1752.
[325] L.-K. Ho, M.-J. Don, H.-C. Chen, S.-F. Yeh, J.-M. Chen, Inhibition of Hepatitis B
Surface Antigen Secretion on Human Hepatoma Cells. Components from Rubia
cordifolia, J. Nat. Prod. 59 (1996) 330–333. https://doi.org/10.1021/np960200h.
[326] S. lodi, V. Sharma, L. Kansal, The protective effect of Rubia cordifolia against lead
nitrate-induced immune response impairment and kidney oxidative damage, Indian J.
Pharmacol. 43 (2011) 441–444. https://doi.org/10.4103/0253-7613.83118.
[327] S.K. Talapatra, A.C. Sarkar, B. Talapatra, Two pentacyclic triterpenes from Rubia
cordifolia,
Phytochemistry.
20
(1981)
1923–1927.
https://doi.org/https://doi.org/10.1016/0031-9422(81)84036-8.
[328] G.M.M. Rao, C. V Rao, P. Pushpangadan, A. Shirwaikar, Hepatoprotective effects of
rubiadin, a major constituent of Rubia cordifolia Linn, J. Ethnopharmacol. 103 (2006)
484–490. https://doi.org/https://doi.org/10.1016/j.jep.2005.08.073.
[329] P.P. Gupta, R.C. Srimal, N. Verma, J.S. Tandon, Biological Activity of Rubia cordifolia
and Isolation of an Active Principle, Pharm. Biol. 37 (1999) 46–49.
https://doi.org/10.1076/phbi.37.1.46.6322.
[330] A. Anantharaman, R.R. Priya, H. Hemachandran, S. Akella, C. Rajasekaran, J. Ganesh,
D.P. Fulzele, R. Siva, Toxicity study of dibutyl phthalate of Rubia cordifolia fruits: in
vivo and in silico analysis, Environ. Toxicol. 31 (2016) 1059–1067.
32
[337]
[338]
[339]
[340]
[341]
Jo
[342]
of
[336]
ro
[335]
-p
[334]
re
[333]
ur
na
lP
[331]
[332]
https://doi.org/10.1002/tox.22115.
Y.B. Tripathi, A.V. Singh, Role of Rubia cordifolia Linn. in radiation protection, (2007).
A. Osama, S. Awadelkarim, A. Ali, Antioxidant activity, acetylcholinesterase inhibitory
potential and phytochemical analysis of Sarcocephalus latifolius Sm. bark used in
traditional medicine in Sudan, BMC Complement Altern Med. 17 (2017).
https://doi.org/10.1186/s12906-017-1772-6.
A. Gansane, S. Sanon, L.P. Ouattara, A. Traore, S. Hutter, E. Ollivier, N. Azas, A.S.
Traore, I.P. Guissou, S.B. Sirima, I. Nebie, Antiplasmodial activity and toxicity of crude
extracts from alternatives parts of plants widely used for the treatment of malaria in
Burkina Faso: contribution for their preservation, Parasitol Res. 106 (2010) 335–340.
https://doi.org/10.1007/s00436-009-1663-y.
N.G.N. Ezeji-Chigbu, A.C. Ene, A.A. Emejulu, Sub-Acute Toxicity Evaluation of
Aqueous Stem Bark Extract of Sarcocephalus latifolius, SciFed J. Anal. Biochem. 1
(2018).
A. V Iwueke, O.F.C. Nwodo, Antihyperglycaemic effect of aqueous extract of Daniella
oliveri and Sarcocephalus latifolius roots on key carbohydrate metabolic enzymes and
glycogen in experimental diabetes, Biokemistri. 20 (2008).
V.H. Enemor, A.N. Okaka, Sub-acute effects of ethanol extract of Sarcocephalus
latifolius root on some physiologically important electrolytes in serum of normal Wistar
albino rats, Pak J Biol Sci. 16 (2013) 1811–1814.
D. Arome, C. Enegide, S. Ameh, A. Agbafor, E. Mbonne, I. Monica, Absence of
anxiolytic activity of Sarcocephalus latifolius fruit extract, J. Pharm. Negat. Results. 5
(2014) 4–7. https://doi.org/10.4103/0976-9234.136772.
S.A. Kaboré, M. Hien, D. Ouédraogo, T.R.E. Diallo, K. Hahn, H.B. Nacro, Use of
Ecosystem Services of Sarcocephalus latifolius (Sm.) E.A.Bruce and Induced Effect of
Human Pressure on the Species in the Southwestern Region of Burkina Faso, 2014. 12
(2014) 10. https://doi.org/10.17348/era.12.0.561-570.
P. Vudriko, M.K. Baru, J. Kateregga, J.G. Ndukui, Crude ethanolic leaf extracts of
Citropsis articulata: A potential phytomedicine for treatment of male erectile
dysfunction associated with testosterone deficiency, Int. J. Basic Clin. Pharmacol. 3
(2014) 120–123.
J. Oloro, P.E. Alele, M. Amanya, J.K. Tanayen, J.O.C. Ezeonwumelu, A.G. Agaba,
Effects of aqueous root bark extract of Citropsis articulata (Swingle Kellerman) on
sexual function in male rats, African J. Pharm. Pharmacol. 9 (2015) 723–729.
D. Olila, O. Olwa, J. Opuda-Asibo, Screening extracts of Zanthoxylum chalybeum and
Warburgia ugandensis for activity against measles virus (Swartz and Edmonston
strains) in vitro, Afr Heal. Sci. 2 (2002) 2–10.
M.N. Kiraithe, J.M. Nguta, J.M. Mbaria, S.G. Kiama, Evaluation of the use of Ocimum
suave Willd. (Lamiaceae), Plectranthus barbatus Andrews (Lamiaceae) and
Zanthoxylum chalybeum Engl. (Rutaceae) as antimalarial remedies in Kenyan folk
medicine,
J.
Ethnopharmacol.
178
(2016)
266–271.
https://doi.org/http://dx.doi.org/10.1016/j.jep.2015.12.013.
P.O. Engeu, R. Tumusiime, M. Agwaya, G. Mugisha, G.N. Kyeyune, B. Galiwango, P.
Waako, Repeat-dose effects of Zanthoxylum chalybeum root bark extract: a traditional
medicinal plant used for various diseases in Uganda, (2008).
L. Bunalema, G.W. Fotso, P. Waako, J. Tabuti, S.O. Yeboah, Potential of Zanthoxylum
leprieurii as a source of active compounds against drug resistant Mycobacterium
tuberculosis,
BMC
Complement
Altern
Med.
17
(2017)
89.
https://doi.org/10.1186/s12906-017-1602-x.
A. Nahayo, M.J. Bigendako, K. Fawcett, H. Nkusi, N.J. B., Y. Gu, Chemical Study of
[343]
[344]
[345]
33
[351]
[352]
[353]
[354]
[355]
[356]
Jo
[357]
of
[350]
ro
[349]
-p
[348]
re
[347]
ur
na
lP
[346]
the Stems of Urtica massaica, a Medicinal Plant Eaten by Mountain Gorillas (Gorilla
beringei beringei) in Pare National des Volcans, Rwanda, Reseach Journals Appl. Sci.
3 (2008) 514–520.
Y.W. Wabai, M.J.K. Maina, N.E. Mwaniki, Teratogenic potential of Urtica massaica
(Mildbr.) and Croton megalocarpus (Hutch) in mice, (2018).
E. Katuura, P. Waako, J. Ogwal-Okeng, R. Bukenya-Ziraba, Traditional treatment of
malaria in Mbarara District, western Uganda, Afr. J. Ecol. 45 (2007) 48–51.
https://doi.org/10.1111/j.1365-2028.2007.00737.x.
F. Ocheng, F. Bwanga, M. Joloba, A.-K. Borg-Karlson, A. Gustafsson, C. Obua,
Antibacterial activities of extracts from Ugandan medicinal plants used for oral care, J.
Ethnopharmacol.
155
(2014)
852–855.
https://doi.org/http://dx.doi.org/10.1016/j.jep.2014.06.027.
G.N. Silva, F.R. Martins, M.E. Matheus, S.G. Leitao, P.D. Fernandes, Investigation of
anti-inflammatory and antinociceptive activities of Lantana trifolia, J Ethnopharmacol.
100 (2005) 254–259. https://doi.org/10.1016/j.jep.2005.02.040.
T. Nagao, F. Abe, J. Kinjo, H. Okabe, Antiproliferative constituents in plants 10.
Flavones from the leaves of Lantana montevidensis Briq. and consideration of structureactivity relationship, Biol Pharm Bull. 25 (2002) 875–879.
S. Juliao Lde, S.G. Leitao, C. Lotti, A.L. Picinelli, L. Rastrelli, P.D. Fernandes, F. Noel,
J.P. Thibaut, G.G. Leitao, Flavones and phenylpropanoids from a sedative extract of
Lantana
trifolia
L,
Phytochemistry.
71
(2010)
294–300.
https://doi.org/10.1016/j.phytochem.2009.10.007.
S. Seyfe, A. Toma, A. Esaiyas, E. Debela, A. Fikru, A. Eyado, Phytochemical screening
and In vivo antimalarial activities of crude extracts of Lantana trifolia root and Premna
oligotricha leaves in plasmodium berghei infected mice, J. Med. Plants Res. 11 (2017)
763–769.
M.M. Budai, A. Varga, S. Milesz, J. Tozser, S. Benko, Aloe vera downregulates LPSinduced inflammatory cytokine production and expression of NLRP3 inflammasome in
human
macrophages,
Mol
Immunol.
56
(2013)
471–479.
https://doi.org/10.1016/j.molimm.2013.05.005.
S.A. Im, K.H. Kim, H.S. Kim, K.H. Lee, E. Shin, S.G. Do, T.H. Jo, Y.I. Park, C.K. Lee,
Processed Aloe vera gel ameliorates cyclophosphamide-induced immunotoxicity, Int J
Mol Sci. 15 (2014) 19342–19354. https://doi.org/10.3390/ijms151119342.
V. Saritha, K.R. Anilakumar, Toxicological evaluation of methanol extract of Aloe vera
in rats, Int. J. Pharm. Biomed. Res. 1 (2010) 142–149.
A. Lagarto Parra, R. Silva Yhebra, I. Guerra Sardiñas, L. Iglesias Buela, Comparative
study of the assay of Artemia salina L. and the estimate of the medium lethal dose (LD50
value) in mice, to determine oral acute toxicity of plant extracts, Phytomedicine. 8
(2001) 395–400. https://doi.org/https://doi.org/10.1078/0944-7113-00044.
A.H. Shah, S. Qureshi, M. Tariq, A.M. Ageel, Toxicity studies on six plants used in the
traditional Arab system of medicine, Phyther. Res. 3 (1989) 25–29.
J. Lee, M.S. Lee, K.W. Nam, Acute toxic hepatitis caused by an Aloe vera preparation
in a young patient: a case report with a literature review, Korean J. Gastroenterol. 64
(2014) 54–58.
G.S. Bbosa, D.B. Kyegombe, A. Lubega, N. Musisi, J. Ogwal-Okeng, O. Odyek, AntiPlasmodium falciparum activity of Aloe dawei and Justicia betonica, African J. Pharm.
Pharmacol. 7 (2013) 2258–2263.
A. Gupta, S. Mahajan, R. Sharma, Evaluation of antimicrobial activity of Curcuma
longa rhizome extract against Staphylococcus aureus, Biotechnol. Reports. 6 (2015) 51–
55. https://doi.org/https://doi.org/10.1016/j.btre.2015.02.001.
[358]
[359]
[360]
34
Jo
ur
na
lP
re
-p
ro
of
[361] A. Frank, S. Abu-Lafi, A. Adawi, J.S. Schwed, H. Stark, From medicinal plant extracts
to defined chemical compounds targeting the histamine H4 receptor: Curcuma longa in
the treatment of inflammation, 66 (2017) 923–929. https://doi.org/10.1007/s00011-0171075-x.
[362] H. Itokawa, Q. Shi, T. Akiyama, S.L. Morris-Natschke, K.-H. Lee, Recent advances in
the
investigation
of
curcuminoids,
Chin.
Med.
3
(2008)
11.
https://doi.org/10.1186/1749-8546-3-11.
[363] G.G.L. Yue, B.C.L. Chan, P.-M. Hon, M.Y.H. Lee, K.-P. Fung, P.-C. Leung, C.B.S.
Lau, Evaluation of in vitro anti-proliferative and immunomodulatory activities of
compounds isolated from Curcuma longa, Food Chem. Toxicol. 48 (2010) 2011–2020.
https://doi.org/https://doi.org/10.1016/j.fct.2010.04.039.
[364] J. Lako, V.C. Trenerry, M. Wahlqvist, N. Wattanapenpaiboon, S. Sotheeswaran, R.
Premier, Phytochemical flavonols, carotenoids and the antioxidant properties of a wide
selection of Fijian fruit, vegetables and other readily available foods, Food Chem. 101
(2007) 1727–1741. https://doi.org/https://doi.org/10.1016/j.foodchem.2006.01.031.
[365] G. Singh, I.P.S. Kapoor, P. Singh, C.S. de Heluani, M.P. de Lampasona, C.A.N. Catalan,
Comparative study of chemical composition and antioxidant activity of fresh and dry
rhizomes of turmeric (Curcuma longa Linn.), Food Chem. Toxicol. 48 (2010) 1026–
1031. https://doi.org/https://doi.org/10.1016/j.fct.2010.01.015.
[366] N. Sittisomwong, V. Leelasangaluk, S. Chivapat, A. Wangmad, P. Ragsaman, C.
Chuntarachaya, Acute and subchronic toxicity of turmeric, Bull Dept Med Sci. 32
(1990) 101–111.
[367] T.N.B. Shankar, N. V Shantha, H.P. Ramesh, I.A.S. Murthy, V.S. Murthy, Toxicity
studies on turmeric (Curcuma longa): acute toxicity studies in rats, guineapigs and
monkeys., Indian J. Exp. Biol. 18 (1980) 73–75.
[368] V.B. Liju, K. Jeena, R. Kuttan, Acute and subchronic toxicity as well as mutagenic
evaluation of essential oil from turmeric (Curcuma longa L), Food Chem. Toxicol. 53
(2013) 52–61.
[369] E.A. Sofowora, R. Hardman, Steroids, phthalyl esters and hydrocarbons from Balanites
wilsoniana
stem
bark,
Phytochemistry.
12
(1973)
403–406.
https://doi.org/https://doi.org/10.1016/0031-9422(73)80028-7.
[370] J.S.S. Martin, The Desert Date and Its Relatives: A Revision of the Genus Balanites,
Kew Bull. 56 (2001) 1–128. https://doi.org/10.2307/4119431.
[371] M. Kamatenesi Mugisha, S. Asiimwe, A. Namutebi, A.-K. Borg-Karlson, E.K. Kakudidi,
Ethnobotanical study of indigenous knowledge on medicinal and nutritious plants used
to manage opportunistic infections associated with HIV/AIDS in western Uganda, J.
Ethnopharmacol.
155
(2014)
194–202.
https://doi.org/http://dx.doi.org/10.1016/j.jep.2014.05.012.
[372] J.S.R. Tabuti, K.A. Lye, S.S. Dhillion, Traditional herbal drugs of Bulamogi, Uganda:
plants, use and administration, J Ethnopharmacol. 88 (2003) 19–44.
https://doi.org/10.1016/s0378-8741(03)00161-2.
[373] Nutan, M. Modi, C.S. Dezzutti, S. Kulshreshtha, A.K.S. Rawat, S.K. Srivastava, S.
Malhotra, A. Verma, U. Ranga, S.K. Gupta, Extracts from Acacia catechu suppress
HIV-1 replication by inhibiting the activities of the viral protease and Tat, Virol. J. 10
(2013) 1–17. https://doi.org/10.1186/1743-422x-10-309.
[374] P. Mandal, S.P. Sinha Babu, N.C. Mandal, Antimicrobial activity of saponins from
Acacia
auriculiformis,
Fitoterapia.
76
(2005)
462–465.
https://doi.org/https://doi.org/10.1016/j.fitote.2005.03.004.
[375] J.N. Kanyara, E.N.M. Njagi, Anti-HIV-1 activities in extracts from some medicinal
plants as assessed in an in vitro biochemical HIV-1 reverse transcriptase assay, Phyther.
35
Jo
ur
na
lP
re
-p
ro
of
Res. 19 (2005) 287–290. https://doi.org/10.1002/ptr.1536.
[376] M.M. Leteane, B.N. Ngwenya, M. Muzila, A. Namushe, J. Mwinga, R. Musonda, S.
Moyo, Y.B. Mengestu, B.M. Abegaz, K. Andrae-Marobela, Old plants newly
discovered: Cassia sieberiana D.C. and Cassia abbreviata Oliv. Oliv. root extracts
inhibit in vitro HIV-1c replication in peripheral blood mononuclear cells (PBMCs) by
different modes of action, J. Ethnopharmacol. 141 (2012) 48–56.
https://doi.org/http://dx.doi.org/10.1016/j.jep.2012.01.044.
[377] C. Reilly, J. Henry, Geophagia: why do humans consume soil?, Nutr. Bull. 25 (2000)
141–144. https://doi.org/10.1046/j.1467-3010.2000.00032.x.
[378] P.W. Abrahams, Geophagy (soil consumption) and iron supplementation in Uganda,
Trop. Med. Int. Heal. 2 (1997) 617–623. https://doi.org/doi:10.1046/j.13653156.1997.d01-348.x.
[379] B. Smith, S.R.N. Chenery, J.M. Cook, M.T. Styles, J. V Tiberindwa, C. Hampton, J.
Freers, M. Rutakinggirwa, L. Sserunjogi, A. Tomkins, Geochemical and environmental
factors controlling exposure to cerium and magnesium in Uganda, J. Geochemical
Explor. 65 (1998) 1–15.
[380] H. Szajewska, P. Dziechciarz, J. Mrukowicz, Meta‐ analysis: smectite in the treatment
of acute infectious diarrhoea in children, Aliment. Pharmacol. Ther. 23 (2006) 217–227.
[381] T. Johns, Detoxification function of geophagy and domestication of the potato, J Chem
Ecol. 12 (1986) 635–646. https://doi.org/10.1007/bf01012098.
[382] P.W. Harvey, P.B. Dexter, I. Darnton-Hill, The impact of consuming iron from nonfood sources on iron status in developing countries, Public Heal. Nutr. 3 (2000) 375–
383.
[383] S.L. Young, Pica in pregnancy: new ideas about an old condition, Annu. Rev. Nutr. 30
(2010) 403–422.
[384] V. Minnich, A. OkÇUoĞLu, Y. Tarcon, A. Arcasoy, Süh. Cin, O. ÖRÜKoĞLu, F.
Renda, B. DemiraĞ, Pica in Turkey: II. Effect of clay upon iron absorption, Am. J. Clin.
Nutr. 21 (1968) 78–86.
[385] S.C. Sheppard, Geophagy: who eats soil and where do possible contaminants go?,
Environ. Geol. 33 (1998) 109–114.
[386] S.L. Simon, Soil ingestion by humans: a review of history, data, and etiology with
application to risk assessment of radioactively contaminated soil, Health Phys. 74 (1998)
647–672.
[387] M.S. Wong, D.A.P. Bundy, M.H.N. Golden, Quantitative assessment of geophagous
behaviour as a potential source of exposure to geohelminth infection, Trans. R. Soc.
Trop. Med. Hyg. 82 (1988) 621–625. https://doi.org/https://doi.org/10.1016/00359203(88)90532-9.
[388] K.C. Chinsembu, M. Hedimbi, An ethnobotanical survey of plants used to manage
HIV/AIDS opportunistic infections in Katima Mulilo, Caprivi region, Namibia, J.
Ethnobiol. Ethnomed. 6 (2010) 1–9. https://doi.org/10.1186/1746-4269-6-25.
[389] D. Langlois-Klassen, W. Kipp, G.S. Jhangri, T. Rubaale, Use of Traditional Herbal
Medicine by AIDS Patients in Kabarole District, Western Uganda, Am. J. Trop. Med.
Hyg. 77 (2007) 757–763. http://www.ajtmh.org/content/77/4/757.abstract.
[390] J.N. Wanyama, S. Tsui, C. Kwok, R.K. Wanyenze, J.A. Denison, O. Koole, E. van Praag,
B. Castelnuovo, F. Wabwire-Mangen, G.P. Kwesigabo, R. Colebunders, Persons living
with HIV infection on antiretroviral therapy also consulting traditional healers: a study
in three African countries, Int. J. STD AIDS. 28 (2017) 1018–1027.
https://doi.org/10.1177/0956462416685890.
[391] O.R. Millington, C. Di Lorenzo, R.S. Phillips, P. Garside, J.M. Brewer, Suppression of
adaptive immunity to heterologous antigens during Plasmodium infection through
36
Jo
ur
na
lP
re
-p
ro
of
hemozoin-induced failure of dendritic cell function, J. Biol. 5 (2006) 5.
https://doi.org/10.1186/jbiol34.
[392] N. Beuscher, C. Bodinet, D. Neumann-Haefelin, A. Marston, K. Hostettmann, Antiviral
activity of African medicinal plants, J Ethnopharmacol. 42 (1994) 101–109.
[393] S. Staines S., Herbal medicines: adverse effects and drug-herb interactions, J Malta Coll
Pharm Pr. 17 (2011) 38–42.
37
of
ro
-p
re
Jo
ur
na
lP
Figure 1: Map of Uganda showing study sites. Adopted from Anywar et al. [23].
38
of
ro
-p
re
ur
na
lP
Jo
Plate 1: Various clay tablets consumed by people living with HIV/AIDS in Uganda
39
Table 2: Languages spoken & Number of TMP interviewed by districts
Districts & Location
1. Arua
2. Dokolo
3. Mbale
4. Iganga
5. Bushenyi
6. Rakai
7. Luwero
8. Kaabong
Language spoken
Lgbara
Luo (Langi)
Lugisu
Lusoga
Runyankore
Luganda
Luganda
Ik
No. of TMP interviewed
11
10
10
15
13
6
13
12
Table 2: Medicinal plants used by TMP to boost the immune system in people living with
HIV/AIDS in Uganda
8. Searsia pyroides (Burch.) Moffett (AG381)
H
L
Jo
Asteraceae
14.Artemisia annua L. (AG392)
15.Arctium lappa L. (AG428)
16.Conyza pyrrhopappa Sch.Bip. ex A.Rich.
(AG397)
17.Echinacea angustifolia DC. (AG419)
18.Senecio hadiensis Forssk (AG451)
19.Vernonia amygdalina Delile (AG405)
Basellaceae
20.Basella alba L. (AG393)
Bignoniaceae
21.Kigelia africana (Lam.) Benth. (AG401)
22.Markhamia lutea (Benth.) K.Schum. (AG367)
23.Stereospermum kunthianum Cham. (AG394)
Canellaceae
24.Warburgia ugandensis Sprague (AG383)
Fr
Method of Preparation
of
Doodo [Lug]
H
H
Sd
L
2
1
Boil & eat large amounts
regularly
Boil with porridge/pop seeds
Infusion made & drunk.
H
H
Blb
Blb
5
3
Crushed & mixed in honey
Crushed & mixed in honey
Mukontambaale [Lus], Kibumbu [Gis]
Muyembe [Lug, Lus, Gis], Mengu
[Lgb], Mahembe [Lan]
Kakwansokwanso [Lug]
T
T
B
B, L
4
7
Sh
L, B
1
Boiled & drunk
Boil powder singly/with other
herbs & drink
Boiled & drunk
Kutukumwe [Ru]
H
L
1
Boiled & drunk
Mugajjangalabi [Lug]
Kafulu [Gis, Lus, Lug]
T
H
B
R
4
4
Boiled & drunk
Boiled & drunk
Mulondo [Lug, Lus], Orono [Lan]
Cl
R
3
Pound, mix with water & drunk
Kajjolyenjovu [Lug], Mugorora [Ru]
T
B, R
3
Boil
with
other
herbs
(drink)/clay tablets (chew
Artemesia*
Burdock*
Kafugankande [Lug], Muhe [Ru],
Yagyag [Lgb]
Echinacea*
Mugina/mubiri [Lug],
Mululuza [Lug], Mubiriizi [Ru]
H
H
H
2
1
5
Drink hot water infusion
Boil & drink
Boil with other herbs & drink
H
H
Sh
L
R
L, B,
R
R, L
L
L
1
1
4
Make tea
Boil, squeeze out juice & drink
Make tea
Nderema [Lug]
H
L
5
Pound, mix in water & drink
Mussa
[Lug],
Mufungedha/
Omwisa/Mussa [Lus], Ibologo [Lgb]
Kufunga/Mwisa [Gis], Omwisya [Ru]
Lusoola [Bisu], Sambya [Lgb]
Kinyasira [Ru],
T
Fr
11
Boil & drink
T
T
R
B
7
1
Boil with other herbs & drink
Boil & drink
Abasi/Omuya [Lug], Balwegiira
[Lus], Mwiha [Ru], Abac [Lang]
T
B
8
Boil & drink
Amaranth*/Doodo [Lug]
Mwenza [Ru]
Katunguluchumu [Lug], Tungl [Lan]
Katungulu [Lug]
ur
na
lP
Apiaceae
9. Centella asiatica (L.) Urb. (AG388)
Apocynaceae
10.Alstonia boonei De Wild. (AG390)
11.Cryptolepis sanguinolenta (Lindl.) Schltr.
(AG480)
12.Mondia whytei (Hook.f.) Skeels (AG373)
Asparagaceae
13.Dracaena steudneri Engl. (AG385)
PU
Capparaceae
40
1
ro
2. Amaranthus sp. (AG362)
3. Aerva lanata (L.) Juss. (AG369)
Amaryllidaceae
4. Allium sativum L. (AG391)
5. Allium cepa L. (AG370)
Anacardiaceae
6. Lannea barteri (Oliv.) Engl. (AG377)
7. Mangifera indica L. (AG401)
Hb
-p
Acanthaceae
1. Amaranthus dubius Mart. ex Thell. (AG361)
Local Names in respective
languages
re
Family, Scientific Name (Voucher No.)
31.Cucurbita maxima Duchesne (AG406)
Euphorbiaceae
32.Jatropha curcas L. (AG429)
33.Manihot esculenta Crantz (AG426)
Fabaceae
34.Acacia hockii De Wild. (AG428)
35.Acacia amythethophylla A.Rich. (AG406)
36.Acacia polyacantha subsp. campylacantha
(A.Rich.) Brena (AG486)
37.Acacia seyal (L.) Willd. (AG570)
38.Albizia coriaria Oliv (AG366)
39.Erythrina abyssinica DC. (AG418)
Boil with millet porridge &
drink
Njagga [Lug], Endaaye [Lus]
H
L
1
Boil with B. micrantha & drink
Paapali/Mupaapali [Lug, Lus, Gis],
Apapalo [Lan], Paipai [Lug]
T
Fr
2
Boil & drink
Mbaluka [Ru]
Sh
B
7
Boil & drink
Odugu [Lan]
T
Ap
4
Boil & drink
Kiyondo-ekyeru [Lug], Kisanaasana
[Lus]
H
L
4
Boil & drink
Local Names in respective
languages
Nsujju [Lug]
Hb
PU
Fr
Method of Preparation
Sc
Fr
2
Eat/ Boil with other herbs
Kiroowa [Lug]
Muwogo [Lug]
T
Sh
Sd
L
Kaasana [Lug], Okuto atino [Lang]
T
B
Sh
Sh
R
R
Muwologoma [Lug]
Kibere [Lug], Morigo [Lgb]
Jo
46.Micromeria biflora (Buch.-Ham. ex D.Don)
Benth. (AG416)
Lauraceae
47.Persea americana Mill. (AG421)
Lythraceae
48.Punica granatum L. (AG423)
Moraceae
49.Milicia excelsa (Welw.) C.C.Berg (AG431)
Moringaceae
50.Moringa oleifera Lam (AG408)
Myrtaceae
51.Psidium guajava L. (AG419)
Passifloraceae
52.Passiflora edulis Sims (AG365)
Phyllanthaceae
53.Bridelia micrantha (AG452)
54.Flueggea virosa (Roxb. ex Willd.) Royle (AG430)
55.Hymenocardia acida Tul. (AG411)
56.Phyllanthus ovalifolus Forssk. (AG376)
Polygalaceae
2
1
Drink cold-water infusion &
Boil & drink
8
2
2
Boil & drink/mix with other
herbs
Boil/Make clay tablets
Boil & drink
Naibeere [Lus]
Mugavu [Lug], Musiita [Lus], Kiluku
[Lgb]
Jjirikiti [Lug], Murinzi/ Muko [Ru],
Oluo [Lgb], Muyirikiti [Lus]
Mwolola [Lug]
Kibundabunzi [Ru]
Sh L,B, Fr
T B, L
4
3
Boil & drink
Boil & drink
T
B
7
Boil & drink
T
Sh
B
L
1
1
Pound, boil & drink
Boil & drink
Mukuna [Lug]
Nkooge [Lug] Eti [Lgb]
Kiyugeyuge [Lus], Nazaka [Lgb]
H
T
Cl
Sd
B, L
B, R
1
3
3
Tea from roasted seed powder
Boil & drink
Boil singly/with other herbs/ add
powder milk &drink
Kamunye [Lug], Nfoodo
Esitimwe [Ru]
Shagamanungi [Ru]
H
L
1
Boil & drink
H
L
1
Boil & drink
Ovakedo [Lug], Vadeko [Lus, Gis]
T
Sd, B
2
Boil & drink
Mukoma mawanga [Lus]
Sh
R, Fr
1
Boil & drink
Muvule [Lug, Lgb]
T
L
2
Boil & drink
Molinga*
T
L, R
4
Boil & drink /add in sauce/stew
Mupeera [Lug], Ipeera [Ru]
T
F
11
Eat fresh
Katunda [Lug, Lus]
Cl
R, Fr
4
Chew/Juice/ boil & drink
Katazamiti [Lug]
Lukandwa [Lug]
Nabbaluka/ [Lug]
Mutulika [Lug]
T
Sh
T
Sh
L, B
Tw
R
L
8
2
1
4
Boil for about 2.5 hrs & drink
Boil with M. indica & drink
Boil & drink
Boil & drink
ur
na
lP
40.Entada abyssinica A.Rich (AG387)
41.Kotschya aeschynomenoides (Bak.) De Wild. &
Devign (AG359)
42.Mucuna pruriens (L.) DC. (AG409)
43.Tamarindus indica L. (AG403)
44.Tylosema fassoglensis (Schweinf.) Torre &
Hillc. (AG414)
Lamiaceae
45.Hoslundia opposita Vahl (AG413)
1
of
Cucurbitaceae
Family, Scientific Name (Voucher No.)
R
ro
Celastraceae
28.Cassine aethiopica Thunb. (AG374)
Combretaceae
29.Combretum collinum sub sp. elgonense (Exell)
Okafa (AG416)
Crassulaceae
30.Kalanchoe densiflora Rolfe (AG427)
Sh
-p
Cannabaceae
26.Cannabis sativa L. (AG410)
Caricaceae
27.Carica papaya L. (AG378)
Mukolokombi [Lug], Mukorokombi
[Ru], Ogadaman [Lan]
re
25.Capparis tomentosa Lam. (AG379)
41
[Lus],
57.Rumex usambarensis (Dammer) Dammer
(AG368)
58.Securida longipedunculata Fresen. (AG363)
Rubiaceae
59.Fleroya rubrostipulata (K.Schu) Y.F.Deng
(AG404)
60.Gardenia ternifolia subsp. jovis-tonantis
(Welw.) Verdc. (AG453)
61.Rubia cordifolia L. (AG454)
62.Sarcocephalus latifolius (Sm.) E.A.Bruce (AG415)
Rutaceae
63.Citropsis articulata (Willd. ex Spreng.) Swingle
& M.Kellerm (AG439)
64.Zanthoxylum chalybeum Engl. (AG632)
Urticaceae
65.Urtica massaica Mildbr. (AG389)
Family, Scientific Name (Voucher No.)
Mufumbi-egyesha [Ru]
H
L
Mukondwe [Lug]
T
R
1
Boil with millet porridge &
drink
Boil & drink /make clay tablets
Muziko [Ru]
T
B
3
Boil & drink/ tea
Mulema /Mulemanjovu [Lug]
T
B
6
Boil & drink
Kasalabakessi [Lus]
Mutaamataamu [Lus]
Cl
Sh
Ap
R
2
1
Boil /make tea.
Add powder to in sauce/stew
Mubolo [Lug]
Sh
B
3
Boil & drink
Entale ya ddungu [Lug]
T
B, R
11
Boil with other herbs/singly
Kicuragyenyi [Ru]
Local Names in respective
languages
H
Hb
L
PU
1
Fr
Eat as a vegetable/add to food
Method of Preparation
Jo
ur
na
lP
re
-p
ro
of
Verbenaceae
66.Lantana trifolia L. (AG375)
Kayukiyuki [Lug]
H
L
1
Boil with other herbs & drink
Xanthorrhoeaceae
67.Aloe vera (L.) Burm.f. (AG398)
Kigagi [Lug], Tikorotot [Ik]
H
L
7
Boil with other herbs/singly
68.Aloe dawei A.Berger (AG380)
Kigagi [Lug]
H
L
1
Boil & drink
69.Aloe sp. (AG399)
1
1
Zingiberaceae
70.Curcuma longa L. (AG383)
Ocaoayom [Lan]
H
Rh
1
Pound, soak in water & drink
Zygophyllaceae
71.Balanites wilsoniana Dawe & Sprague (AG400)
Naggwalimu [Lug]
T L
1
Boil with other herbs & drink
Key: Habit (Hb): Cl – Climber, H–Herb, Sc–Scrambler, Sh–Shrub, T–Tree, Part Used (PU): Tw– Sd–Seed, B–Bark, Twigs,
L=Leaves, F–Fruit, Fr–Fronds, Rt–Root, Pl–Peel, Ap –All aerial parts:. Blb–Bulb, Rh–Rhizome; Fr – Frequency of mention,
* No local name. Western name adopted Languages: [Gis] –Lugishu, [Lus] –Lusoga, [Lug] –Luganda, [Lgb] –Lugbara, [Lan] –
Langi, [Ik] –Ik, [Ru] –Runyankore. NB: Water is used for preparing all the herbal medicines unless otherwise stated
42
Jo
ur
na
lP
re
-p
ro
o
f
Table 3: Cross reference of medicinal plants species used to boost the immune system in PLHIV in Uganda
Family & Scientific name
Relevant pharmacological activity,
Toxicity
phytochemistry
Acanthaceae
1. Amaranthus dubius Mart.
Antifungal & antibacterial [28]. Alkaloids, No reports. However, A. hybridus is not toxic against brine
ex Thell.
flavonoids, steroids, tannins [29], rutin [30].
shrimp (LC50 6233.6 μg/ml) [31].
2. Amaranthus sp.
No reports
No reports
3. Aerva lanata (L.) Juss.
Immunomodulatory [35], anti-inflammatory [36] The aqueous extract is relatively safe on acute oral exposure,
antimicrobial
[37]
antidiarrheal
[38] LD50 = 22.62 g/kg body weight (bw), moderately toxic on
hepatoprotective [39], anti-HIV, [40]. Phenolics, acute intraperitoneal (i.p) administration (LD50 =
e.g. gallic acid, apigetrin, rutin & myricetin, 0.432 g/kg bw), but relatively safe during prolonged
phytosterols, antimycobacterial [41].
exposure in albino mice [42].
Amaryllidaceae
4. Allium sativum L.
In vitro viricidal effects & antiviral activity. A. sativum generally safe [47] but some side effects of
Diallyl thio-sulfinate (allicin), allyl methyl excessive ingestion in humans include gastrointestinal
thiosulfinate, methyl allyl thiosulfinate, ajoene, discomfort, nausea, bloating, headache, dizziness, profuse
alliin, deoxyalliin, diallyl disulfide, & diallyl sweating, life-threatening haemorrhage when used with
trisulfide [43], antimicrobial [44] antiproliferative anticoagulants [47–49].
[45], immunomodulatory [46].
5. Allium cepa L.
Quercetin, phenolics [53]. Antimicrobial [44]
The crude extract is cytotoxic against tumoral Lucena MDR
immunomodulatory [54].
human erythroleukemic & K562 cell lines [55].
Anacardiaceae
6. Lannea barteri (Oliv.)
Tannins, flavonoids, steroids, quinones, saponins Orally administered methanol extracts were non-toxic (LD50
Engl.
& alkaloids [58,59]. Antiviral [59], antibacterial > 2500 mg/kg bw) in acute toxicity tests in Swiss albino
[60], anticonvulsant [61].
mice [62]. The i.p administered ethanol extract (LD50 =
565.7) was toxic to the same mice [61].
7. Mangifera indica L.
Protocatechic acid, catechin, mangiferin, alanine, Leaf extracts are non-toxic in ICR mice in acute & long-term
glycine, γ–aminobutyric acid [63], triterpenoid & toxicity studies up to 18.4 g/kg bw [66] & not genotoxic or
flavonoids.
Antimicrobial
[64].
Anti- clastogenic in vivo in mammalian micronucleus test up to
inflammatory & immunomodulatory. Nutritional 2000 mg/kg bw [67].
supplement in AIDS & cancer [65].
8. Searsia pyroides (Burch.)
Antiviral bioflavonoids e.g. agathisflavone, No reports
Moffett
amentoflavone, hinokiflavone, rhusflavanone &
succedaneaflavone [68,69].
Apiaceae
43
Relevant reported traditional uses
Anaemia [32]. Malaria [33]. Widely
consumed nutritious vegetable [34].
Inappetence, cough, nausea, flu [23].
Inflammation, skin diseases, dysentery &
diarrhoea [35].
Febrile convulsions [50], infections [51],
cough [52].
TB [56], malaria [57].
Diarrhoea, wounds, gastritis [58] fever
[23].
Cough, convulsions [32,50], malaria
[33], dysentery, stomach ache, anaemia,
diarrhoea, skin infections [23].
Malaria [33], HIV/AIDS [70], diarrhoea,
wounds [71], dysentery [72], skin rash
[32] stomach ache [50].
11. Cryptolepis sanguinolenta
(Lindl.) Schltr.
12. Mondia whytei (Hook.f.)
Skeels
Asparagaceae
13. Dracaena steudneri Engl.
15. Arctium lappa L.
16. Conyza pyrrhopappa
Sch.Bip. ex A.Rich.
f
Relevant reported traditional uses
Ulcers [32], malaria [78], HIV/AIDS
[70,79], dermatitis [50], skin infections
[23].
Toxic to rats at high doses [84].Various fractions of A.
boonei extracts were both hepatotoxic & nephrotoxic in rats
at 400 mg/kg bw [85].
The aqueous root extract is generally safe in Sprague
Dawley rats (LD50 > 3000 mg/kg bw) [91].
Malaria [23,32,86].
Aqueous extracts were non-toxic in acute & sub-chronic
toxicity studies on Wistar rats at single dose exposure up to
the limit 5000 mg/kg after 90 days [96].
Loss of appetite [23,32], fever, malaria,
infections [23,90].
Antifungal [97].
No reports
Cough, syphilis, skin infections, TB,
cough [23,32], malaria [33].
Immunomodulatory with flavonoids, phenolics,
artemisinin
[98],
antiplasmodial
[99],
antimicrobial [100], anticancer [101].
The hydro-ethanolic extract was not toxic in Swiss mice up
to 5000 mg/kg bw [102]. The essential oils have low relative
toxicity in mice when administered i.p (LD50 = 1400 &
1832mg/kg for different samples [103]. Artemisinin is
relatively safe & nontoxic in humans (LD50 > 5000 mg/kg
[104].
The ethanolic root & fruit extracts are not toxic to SpragueDawley albino rats [111] & Wistar rats (LD50 > 5000 mg/kg)
in oral acute & sub-acute toxicity tests [112]. Very few side
effects from root preparations can occur in humans [113].
No reports
Malaria [33], wounds, intermittent fevers
[105].
Alstonine [80], alkaloids, saponins, flavonoids,
tannins, glycosides, resins, steroids & triterpenes
[81]. Anti-inflammatory [82] & antiarthritic [83].
Antiplasmodial containing with cryptolepine,
cryptoheptine, like [87], antimycobacterial with
tannins & flavonoids [88], antimicrobial with
polyuronides, anthocyanosides & triterpenes [89],
anti-inflammatory [90].
Antiinflamatory & antibacterial [93]. 2-hydroxy4-methoxybenzaldehyde
[94]
phenolics,
flavonoids & tannins [95].
Jo
ur
Asteraceae
14. Artemisia annua L.
re
-p
ro
o
Apocynaceae
10. Alstonia boonei De Wild.
Toxicity
The acetone extract was non-toxic in Swiss mice (LD50 <
4000mg/kg bw) [76]. Crude extracts were non-toxic to
normal human lymphocytes [77].
lP
9. Centella asiatica (L.) Urb.
Relevant
pharmacological
activity,
phytochemistry
Asiatic acid, asiaticoside & madecassic acid [73].
Tannins, essential oils, phytosterols, mucilages,
resins, flavonoids, an alkaloid (hydrochotine),
vallerine, fatty acids (linoleic acids, linoleic, oleic,
palmitic
and
stearic
acids)
[74]
Immunomodulatory [75].
na
Family & Scientific name
Anti-HIV-1, Wedelolactone, orobol [106], antiinflammatory [107], immunomodulatory [108].
Phytoalexins
[109],
lignans;
arctigenin,
matairesinol, arctiin, lappaol A, C & F [110].
Saponins, tannins, alkaloids, steroid glycosides,
flavonoid, anthrasenosides, triterpenes [115].
44
Malaria [92], fever, malaria, infections
[90].
Arthritis & cancer in Traditional Chinese
Medicine [110], infections [114].
Malaria [33], diarrhoea, headache [23].
18. Senecio hadiensis Forssk
19. Vernonia auriculifera
Hiern
Basellaceae
20. Basella alba L.
Antimicrobial,
sesquiterpene
amine
farnesylamine, lupenyl acetate, oleanolic acid, βamyrin acetate, amyrin, friedelanone, friedelin
acetate, α-amyrin & β-sitosterol [127], 8desacylvernodalol [128].
na
Wound healing, anti-viral, anti-ulcer, antiinflammatory &
hepatoprotective
[131].
Alkaloids, phenols, flavonoids [132].
Antibacterial
&
antifungal
immunomodulatory [134].
Jo
ur
Bignoniaceae
21. Kigelia africana (Lam.)
Benth.
[133],
22. Markhamia lutea (Benth.)
K. Schum.
Antiviral with phenylpropanoid glycosides e.g.
luteoside A, B & C [137]. Anti-parasitic [138].
23. Stereospermum
kunthianum Cham.
Antiplasmodial,
anticonvulsant
with
naphthoquinones & anthraquinone [140].
Antimicrobial [141]. Antiinflamatory
[142]
Sterols/ triterpenes, coumarins [143].
Relevant
pharmacological
activity,
phytochemistry
Family & Scientific name
f
Toxicity
re
-p
ro
o
17. Echinacea angustifolia
DC.
Relevant
pharmacological
activity,
phytochemistry
Immunostimulatory [116], antiviral [117],
antifungal & antibacterial [118]. Alkamides;
caffeic acid esters, particularlyechinacoside;
cynarin; polysaccharides; polyacetylenes [119].
Anti-inflammatory with sesquiterpenoids &
presilphiperfolan [121]. Pyrrolizidine alkaloids
[122].
lP
Family & Scientific name
Relevant reported traditional uses
Single oral/i.v doses many times the human therapeutic
doses of the juice were non-toxic to rats & mice after 4
weeks, with no mutagenicity/carcinogenicity reported in
hamster embryo cells [120].
The pyrrolizidine alkaloids (PA) [122] in Senecio genus are
acutely toxic, genotoxic & teratogenic to vertebrates &
invertebrates [123]. Ingestion of PA in humans in herbal
products is associated with acute & chronic liver toxicity
[124].
No information is available on the possible irritant or toxic
properties [129].
Colds, influenza
infections [118].
No reports
Stomach ache, constipation [32].
Low doses of aqueous fruit extract are safe but may have
some hepatorenal toxic effects in Wistar albino rats at higher
doses (500 mg/kg bw) [135]. Aqueous leaf extracts also
potentially toxic to liver & kidney, LD50 > 3000 mg/kg bw
[136].
No reports. However, 80% aqueous methanol leaf extract of
M. platycalyx is non-toxic in Swiss albino mice [139].
HIV/AIDS [23,70], syphilis, stomach
ache [50].
Sub-acute oral administration of aqueous bark extract was
not toxic to rats after 28 days [144].
Toxicity
Canellaceae
45
[117],
respiratory
HIV/AIDS OI [125], cancer [126],
fatigue, stomach ache [23].
Fever [130], cancer [126], syphilis,
fatigue [23].
Ear & eye infections [32], malaria
[32,33], skin infections, anaemia,
inappetence, stomach ache [23].
Bronchitis, pneumonia, coughs, gastritis,
wounds, rheumatic arthritis, ulcers,
dysentery & venereal diseases, febrile
convulsions [142], malaria & fevers [23].
Relevant reported traditional uses
Caricaceae
27. Carica papaya L.
HIV/AIDS, coughs, TB, fevers,
diarrhoea, skin rashes, sores, thrush &
STI, herpes zoster, simplex [156,157],
diarrhoea [23].
Antidepressant [158], anti-nausea [159], antinociceptive [160], anti-inflammatory & anti-HIV1 [161], immunomodulatory [162], anticancer
[163], antibacterial [164]. Phytocannabinoids e.g.
delta8-tetrahydrocannabinol,
cannabigerol,
cannabinol [165].
Frequent and prolonged use of cannabis produces both
mental & physical impairment, mood disorders,
exacerbation of psychotic disorders in vulnerable people,
cannabis
use
disorders,
withdrawal
syndrome,
neurocognitive impairments, cardiovascular & respiratory
diseases [166,167].
Body weakness [32], cough, TB, pain,
asthma, diarrhoea [23].
Antifungal, antimalarial [168], anticancer [169], Sub-acute oral toxicity tests of the leaf extracts in Sprague
nephroprotective
[170], immonomodulatory Dawley rats at up to 2 g/kg, (14 times the levels used in
[168,171]. Polysaccharides, glycosides, saponins, traditional medicine in Malaysia is safe [173,174].
flavonoids & phytosterols [172].
Cough, low immunity, measles erectile
dysfunction [32], abdominal pain [50],
malaria [33], skin infections, ulcers,
cough, anaemia [23].
Combretaceae
29. Combretum collinum
sub sp. elgonense (Exell)
Okafa
Crassulaceae
30. Kalanchoe densiflora
Rolfe
f
Leaf extracts were toxic to Nubian goats, sheep & calves
when ingested given daily at doses ranging from 0·05 to
5g/kg/day. The main signs of poisoning were inappetence,
muscular weakness, incoordination of movement, pain in the
sacral region, dragging of the hind limbs, pallor of the visible
mucous membranes & recumbency [154,155].
Jo
ur
Celastraceae
28. Cassine aethiopica Thunb.
Antibacterial, wound healing [152]. Oxindole (3hydroxy-3-methyl4methoxyoxindole) [153].
re
-p
ro
o
Cannabaceae
26. Cannabis sativa L.
Extracts are safe to use with no mortality at all dose levels
(LD50 > 5000 mg/kg bw) in BALB/c mice [150].
lP
Capparaceae
25. Capparis tomentosa Lam.
Immunostimulatory [145], antimicrobial [146],
anti-inflammatory
[147].
Ugandensolide,
ugandensidial,
muzigadial,
polygodial,
waburganal,
cinnamolide,
mukaadial,
muzigadiolide [148,149].
na
24. Warburgia ugandensis
Sprague
TB & HIV/AIDS [79,151], flu, cough
[32], malaria [23,32,50].
No reports
No reports
Headaches [175], inappetence, syphilis,
sexual dysfunctions [23].
Glucuronic,
galacturonic
&
4-Omethylglucuronic acid, galactose, arabinose,
rhamnose, mannose, xylose & gum [176].
No reports
Diarrhoea, pyomyositis & gonorrhoea
[151], dysentery [177].
Anti-inflammatory [178], antibacterial, tannins,
saponins, terpenoids, flavonoids and cardiac
glycosides [179].
No reports but K. brasiliensis extracts had no acute toxicity
on mice at 5 g/kg i.p [180].
Stomach & earache [23,181], wounds
[182], fevers, cough, fatigue, ulcers,
anaemia [23].
46
33. Manihot esculenta Crantz
Fabaceae
34. Acacia hockii De Wild.
38. Albizia coriaria Oliv
f
Relevant reported traditional uses
Antimicrobial, antidiarrheal [183] cucurbitacins
[184].
Flavonoids,
saponins,
tannins.
Immunomodulatory & antitumour [185].
Cucurbitaxanthin a & b [186].
The seeds are non-toxic to mice after oral administration
(LD50 > 5000 mg/kg bw [187] & pigs in oral acute & subacute tests [188].
Malaria [33], fatigue [23].
Anti-HIV [189], immunomodulatory [190], antiinflammatory
[191],
anticancer
[192].
Jatrophalactone, Jatrophalone, Jatrophadiketone
[193], Curcusone B [192], curcin [194], phorbol
esters [195].
Anti-inflammatory [201]. Cyanogenic glycoside
(i.e. linamarin & lotaustralin) [202], pentacyclic
triterpenoids maesculentins A & B [203].
Known to be toxic. Aacute poisoning due to accidental
ingestion of the seeds caused nausea, vomiting & abdominal
cramps [196,197]. The purified phorbol esters isolated from
the oil are highly toxic to Swiss Hauschka mice (LD50 =
27.34 mg/kg bw [195].
Has potentially toxic levels of cyanogenic glucosides,
constituting linamarin (95% of total cyanogen content) and
lotaustralin (5%) [204].
Malaria
[198],
arthritis
[199],
gonorrhoea, dysentery [200], fatigue
[23].
Antipyretic [206].
No reports
No reports
TB & HIV/AIDS [23,70,79], oedema
[32], anaemia [50].
Diarrhoea [23].
No reports
Fatigue, gonorrhoea, skin infections [23].
The ethanol extract was cytotoxic to the non-tumour cell
lines, (HUVEC), CC50 = 204 μg/ml) and MRC-5, CC50 =
575 μg/ml [209].
Albizia spp. contain a toxic compound, 4′Methoxypyridoxine that is a vitamin B6 antagonist [215].
Methanol seed extracts of 9 Albizia spp. have varying
degrees of acute toxicity via the i.p & oral routes of
administration in OF-1 Albino mice with various disorders
e.g. nervous system disturbances, hepatic functional
impairment. A. greveana (LD50 = 1.13-2 mg/kg) & A.
tulearensis (LD50 = 2.9-3.2 mg/kg) were the most toxic
[216].
Rheumatoid arthritis [211], fever, blood
tonic, skin infections, diarrhoea, fatigue
[23].
Skin rash [32,33], cough [52], malaria
[33], HIV/AIDS [70,79], cancer, heart
diseases, allergy, nausea, headaches, skin
lesions, fatigue [23].
No reports
No reports
Antibacterial [207], antitumour anti-inflammatory
[208,209], phenols, flavonoids [208], gum,
arabinogalactan-protein [210].
Antiplasmodial [212]. Oleanane-type saponins, A
and B, with anticancer [213]. Oriariosides saponin
& gummiferaoside. Lupeol, Lupenone, Betulinic
& Acacic acid lactone, (+) – Catechin and Benzyl
alcohol [214].
Jo
ur
35. Acacia amythethophylla
A.Rich.
36. Acacia polyacantha subsp.
campylacantha (A.Rich.)
Brena
37. Acacia seyal (L.) Willd.
Toxicity
re
-p
ro
o
Euphorbiaceae
32. Jatropha curcas L.
activity,
lP
Cucurbitaceae
31. Cucurbita maxima
Duchesne
Relevant
pharmacological
phytochemistry
na
Family & Scientific name
47
Fever [52], headache and pain [205],
fatigue [23].
39. Erythrina abyssinica DC.
f
Relevant
pharmacological
activity, Toxicity
phytochemistry
Anticancer, pterocarpans [217]. Antimalarial The root bark is relatively safe (LD50 = 776.2 mg/kg bw) in
[218], anti-mycobacterial, alkaloids, tannins the acute toxicity tests on mice [88].
flavones [88]. Flavonoids [219].
re
-p
ro
o
Family & Scientific name
40. Entada abyssinica A.Rich
Antimicrobial [220]. A diterpene kolavenol,
trypanocidal [221], anti-inflammatory [222].
No toxicity in mice fed on 80% ethanol extract of E.
abyssinica aerial parts up to 2000 mg/kg bw in Theiller’s
original albino mice [223].
41. Kotschya
aeschynomenoides (Bak.)
De Wild. & Devign
42. Mucuna pruriens (L.) DC.
No reports
No reports
Antiadhesive against Helicobacter pylori [243].
6-furanoflavones,
hoslunfuranine,
5Omethylhoslunfuranine, hosloppin, hoslundin,
oppositin [244–246].
Antibacterial [249], anti-inflammatory, analgesic
& antipyretic. Essential oils sesquiterpenoids;
Crude extract not toxic in Swiss albino mice at a dose of
2000 mg/kg bw [247].
na
lP
The ethanol seed extract had no mortality. Male albino
Wistar rats showed normal behaviour at doses of 250 and
2500 mg/kg bw [228] after ingestion of the extract. The
ethanolic leaf extract was nontoxic in Sprague Dawley rats
(LD50 < 5 g/kg) [229].
Jo
ur
43. Tamarindus indica L.
Anti-inflammatory. Slows progression of
Parkinson’s disease, immunomodulatory [224],
hepatoprotective [225]. Tetrahydroisoquinoline
alkaloids [226], L-DOPA & ursolic acid.
Catechols, γ-Sitosterol, caprolactam, vanillin
lactoside, protocatechuic acid [227].
Anti-bacterial,
anti-inflammatory
[231],
immunomodulatory [232], chemoprotective
[233]. Phenolics, proanthocyanidins, arabinose,
triterpenes, apigenin, luteolin [234].
Antiplasmodial [240], essential oils [241].
Phytoestrogens, lignans secoisolariciresinol,
lariciresinol & pinoresinol [242]
44. Tylosema fassoglensis
(Schweinf.) Torre & Hillc.
Lamiaceae
45. Hoslundia opposita Vahl
46. Micromeria biflora (BuchHam. ex D.Don) Benth.
Relevant reported traditional uses
Yellow fever, convulsions, anaemia,
nausea [32], OI [70,79], malaria [33],
TB, syphilis [50], mental illness, chest
pain, skin, infections/ lesions, ulcers,
cancer, stomach aches, diarrhoea, STI,
fevers [23].
Weakness, oral sores [32], cough,
fever/malaria, skin infections, wounds
[32,50], HIV/AIDS OI [23,70], OI,
cancer, mental illness, syphilis [23].
Diarrhoea [23].
Parkinson’s disease [230], mental illness,
fatigue [23].
T. indica extracts are generally safe [235]. The alcohol Convulsions, stomachache [32,237],
extract of stem bark showed no signs of toxicity up to of wound healing, malaria, fever [238]
diarrhoea [23,238], cough, liver diseases
2000 mg/kg/p.o [233,236]
[23], dysentery [238,239].
No reports
Syphilis & jaundice [23,151], diarrhoea,
fatigue, fever, convulsions, wasting [23].
Considered non-toxic. Both hydro-alcoholic extracts &
essential oil did not cause any behavioural changes or deaths
in acute & sub-acute toxicity tests in mice [250].
48
Malaria [32,33], skin infections [23,32],
diarrhoea, yellow fever [52], HIV/AIDS
[79], oral disease [248], ulcers, anaemia
& fatigue [23].
Kidney stones [251].
Moraceae
49. Milicia excelsa (Welw.)
C.C.Berg
Myrtaceae
51. Psidium guajava L.
Passifloraceae
52. Passiflora edulis Sims
f
Immunomodulatory
effects
[252].
Antiinflammatory [253], antibacterial against H.
plylori [254], antiproliferative properties [255],
quercetin, rutin, luteolin, apigenin [256].
Seed extract not toxic (LD50 > 10 g/kg) in acute & sub-acute
oral studies in rats [257]. Leaf extracts not toxic in oral & i.p
toxicity studies in mice (LD50 > 10 g/kg) [253]. Not
genotoxic [258]
Cough [32], diarrhoea [125], HIV/AIDS
OI [79], TB [23,259].
Antiviral
[260],
antimicrobial
[261],
immunomodulatory,
antiiflamatory
[262].
Phenolics [263], gallotannins, ellagitannins,
ellagic acid & anthocyanins [264].
The fruit extract was not toxic in chick embryo model at
doses < 0.1 mg/g in both male & female OF-1 mice (LD50 =
731 mg/kg) i.p [265].
Diarrhoea, inflammation, infections,
dysentery, stomach ache, for healing
wounds [266,267].
Wound-healing,
antibacterial
[268].
Atalantoflavone,
neocyclomorusin,
6geranylnorartocarpetin,
cudraxanthone
&
betulinic acid [269], tannins, saponins, flavonoid,
terpenoids, cardiac glycosides [270].
Ethanol extract is not toxic (LD50 > 5000 mg/kg) in mice
[271].
Skin rash, burns [23,32], malaria [33],
wounds, diarrhoea OI [23].
Immunostimulatory [272], antibacterial with
alkaloids,
polyphenols,
flavonoids,
anthraquinones, coumarins, tannins, triterpenes,
sterols, saponins [273].
Leaves are genotoxic at supra-supplementation levels of
3000 mg/kg bw but are safe at levels ≤ 1000 mg/kg bw in
rats [274]. Aqueous leaf extract is relatively safe when
administered orally (LD50 = 1585 mg/kg) in male Wistar
albino mice [275]. In Swiss albino mice the LD50 of ethanol
extract was 17.8 g/kg & 15.9 g/kg for the aqueous extract&
thus non-toxic [276].
Malaria, fatigue, inappetence, cough
[23,239], HIV/AIDs infections, chronic
anaemia & cancer [277].
Meroterpenoids with antitumor activity [278].
Antibacterial [279] & antiinflamatory [280],
immunomodulatory [281].
The aqueous leaf extracts were not-toxic to rats/mice (LD50
> 5 g/kg, p.o.), 100 times the recommended dose for the
treatment of diarrhoea [282].
Cough, diarrhoea [50], epilepsy, skin
rashes [23].
Antibacterial [273,283], hepatoprotective [284],
anticancer [285], antifungal, anti-inflammatory
[286]. Ionone-I & II, passifloric acid methyl ester
Orally administered leaf extracts are not toxic in Wistar
albino rats up to 2000 mg/kg bw [287]. Acute human
toxicity of aqueous leaf extracts showed that 9 volunteers
Weakness [32], skin rash [50], fatigue,
diarrhoea [23].
Jo
ur
Moringaceae
50. Moringa oleifera Lam
re
-p
ro
o
Lythraceae
48. Punica granatum L.
Relevant reported traditional uses
lP
Lauraceae
47. Persea americana Mill.
Toxicity
na
Family & Scientific name
caryophyllene oxide, epi-α-cadinol, β-eudesmol,
oplapanone, α-Terpeneol [250].
Relevant
pharmacological
activity,
phytochemistry
49
54. Flueggea virosa (Roxb. ex
Willd.) Royle
55. Hymenocardia acida Tul.
58. Securida longipedunculata
Fresen.
Family & Scientific name
Rubiaceae
59. Fleroya rubrostipulata (K.
Schum) Y.F.Deng
f
presented with enhanced values of serum amylase the day
after ingestion indicating pancreatic tissue toxicity.
However, it had no hypnotic-sedative effects to humans &
animals [288].
Toxicity
The dichloromethane (LC50 = 32.0 μg/ml) [293] & ethanol
(LC50 = 30 µg/ml) root extracts [72] were mildly toxic to
brine shrimp. Oral administration of the stem bark extract in
male Wistar rats was well-tolerated without any deaths or
clinical signs of toxicity after 48 hours at 2000 mg/kg [294].
Antiplasmodial with alkaloids: securinine & Orally administered extracts caused no death in rats up
viroallosecurinine [296].
10,000mg/kg bw in acute toxicity tests [297].
Antiamoeabic: tannins, steroids, alkaloids, H. acida extracts were toxic to brine shrimp (LD50 =
saponins
[298],
antimycobacterial
[299], 24.12µg/ml) & mutagenic in vivo [303].
antiinflamatory
&
antinociceptive
[300],
antiplasmodial [301], friedelanone & other
triterpenoids [302].
No reports
No reports, but other species e.g. P. amarus are non-toxic
Antiviral-against HIV-1 RT [289], antidiarrhoeal,
antiinflammatory, antimalarial, antinociceptive
[290]. Phenolics [291], alkaloids, flavonoids,
steroids, tannins & saponins [292].
Antibacterial [305]. Antifungal [97].
Jo
ur
56. Phyllanthus ovalifolus
Forssk.
Polygalaceae
57. Rumex usambarensis (Da
mmer) Dammer
activity,
lP
Phyllanthaceae
53. Bridelia
micrantha
(Hochst.) Baill
Relevant
pharmacological
phytochemistry
na
Family & Scientific name
triterpenes,
re
-p
ro
o
[283]. Polyphenols, flavonoids,
sterols, saponins [285].
Antiplasmodial [308], anti-inflammatory [309],
antimycobacterial [310], antibacterial [311].
Methylsalicylate [312]. Alkaloids, cardiac
glycosides, flavonoids, saponins, tannins, volatile
oils,
terpenoids
&
steroids
[313],
securidacaxanthone [314].
Relevant
pharmacological
activity,
phytochemistry
Antiplasmodial [320].
(LD50 = 774.6mg/kg bw)[304].
Relevant reported traditional uses
Cancer [295], malaria [52], HIV/AIDS
[79], pain, cough, chest pain [23].
Measles [50], OI [23].
Sinuses [32], diarrhoea [298], skin
infections, fatigue [23].
Cough [50], mental illness, aches & OI
[23].
No reports. Toxicological studies of other Rumex spp &
their isolated compounds are limited. Most reports show no
toxicity/mortality at the effective doses [306].
The root extract is relatively toxic to brine shrimp (LC50 =
74.18 & 77.1 μg/ml) respectively [315,316] Extracts from S.
longepedunculata contain salicylates which can cause
ischemic renal damage [317]. LD50 = 1.74 g/kg & 0.02 g/kg
in oral & i.p. respectively for acute toxicity of the root
extract in albino mice [318].
Toxicity
Malaria, diarrhoea [307], gonorrhoea
[305], sore throat, allergies [23].
No reports
Malaria, [50], stomach aches, TB &
respiratory infections [23].
50
Malaria, fever, gonorrhoea [319], cough,
fever, TB [308], ulcers, diarrhoea,
fatigue, OI [23].
Relevant reported traditional uses
Antiplasmodial [321]
The aqueous fruit extract of G. ternifolia was safe in Wistar
albino rats at low doses [322].
f
60. Gardenia ternifolia subsp.
Rutaceae
63. Citropsis articulata
(Willd. ex Spreng.)
Swingle & M. Kellerm
64. Zanthoxylum chalybeum
Engl.
Cough, TB [32], haemorrhoids [50],
inappetence, fatigue [23].
The aqueous stem bark and root extracts are relatively safe
at lower doses in sub-acute toxicity tests in Wistar albino rats
up to 500 mg/body [334] and Sprague-Dawley rats when
administered orally (LD50 >5000 mg/kg bw) [335]. The
ethanol extracts of the roots & fruit are also safe in Wistar
albino rats [336,337].
stomach ache, malaria, diarrhoea, pain,
cough, fever, headache [338], swelling,
vomiting, inappetence STI [23].
Antimalarial & antiplasmodial; omubioside,
katimborine coumarins, alkaloids, trigonelline &
limonoid (obacunyl acetate) [218]. Saponin,
tannins, glycosides [339].
Skimmianine with in vitro antiviral activity
against measles virus [341] Fagaramide [78].
The crude aqueous leaf extract was nontoxic in Swiss albino
mice (LD50 = 18,985 mg/kg bw) [115]. However, the
aqueous root bark was slightly toxic (LD50 = 9486.83 mg/kg
bw) in male Wistar rats [340].
The root extract is not toxic at 2000 mg/kg/ bw in Swiss
albino mice [342]. Long term administration of low doses of
the root bark extract is safe in experimental animals at 4000
mg/kg. High doses may be associated with impaired renal
function & intestinal neoplasms [343].
Diarrhoea, fatigue, inappetence [23].
Antibacterial [305], anthocyanins, flavonoids,
saponins, sterols & tannins [345].
Aqueous extracts are generally safe in acute toxicity & subchronic studies in male Wistar rats at single dose exposure
up to the limit of 5000 mg/kg. Low level renal toxicity
observed after exposures for 90 days [96]. U. massaica is
teratogenic in Swiss albino mice [346].
Gonorrhoea [305].
Antiplasmodial [347], antibacterial [348]. Antiinflammatory [349], Antiproliferative, flavone
glycosides [350]. Eupatorin, apigenin, cirsilineol
[351].
The ethanol root extract was safe in mice (LD50 > 5000
mg/kg bw), with no signs of morbidity & significant
behavioural & physical changes in rats [352], but are mildly
toxic to brine shrimp (LC50 = 32.3 μg/ml) [293]. No acute
toxic effect was detected at relatively high doses
Malaria, yellow fever, diarrhoea, cough,
fever [50,52] OI [23].
Jo
ur
Urticaceae
65. Urtica massaica Mildbr.
The crude ethanolic extracts of the fruits in Swiss albino
mice are not toxic (LD50 > 1000 mg/kg bw) [330]. The LD50
of the alcoholic root extract of R. cordifolia is 1200 mg/kg
bw [331].
lP
62. Sarcocephalus latifolius
(Sm.) E.A. Bruce
Verbenaceae
66. Lantana trifolia L.
Malaria [323], [259], fatigue, fever [23].
Antibacterial [324], hepatoprotective [325],
antiviral (hepatitis B) [325], immunomodulatory
[326]. Rubicoumaric & rubifolic acid [327],
rubiadin [328], aphthohydroquinones, mollugin,
furomollugin, rubilactone [325,329].
Phenolic, flavonoids, caffeic acid [332].
Antiplasmodial [333].
na
61. Rubia cordifolia L.
re
-p
ro
o
jovis-tonantis (Welw.)
Verdc.
51
TB [344], HIV/AIDS [79,259], oral
disease [248], cancer, stomach aches,
cough [32], mental illness [23].
68. Aloe dawei A.Berger
69. Aloe sp.
Zingiberaceae
70. Curcuma longa L.
ameliorates
Relevant reported traditional uses
The methanol extract (at 1, 2, 4, 8 16g/kg bw) did not
produce significant toxic effect in Wistar rats during acute
& sub-acute tests rats [355]. The aqueous leaf extract is toxic
(LD50 = 120.65) in Swiss albino mice [356]. The percentage
lethality was significant in mice chronically treated with A.
vera extracts [357]. In a medical case report, a 21-year-old
female patient was diagnosed with A. vera-induced toxic
hepatitis after admission with acute hepatitis after taking an
A. vera preparation for 4 weeks [358].
No reports
Stomach ache, malaria, wasting [23,32].
No reports
No reports
Antimicrobial, curcuminoids [360], antiinflammatory
[361],
anti-HIV
[362],
immunomodulatory [363]. Fisetin, quercetin &
myricetin [364]. α & β-turmerone, α–santalene,
aromatic-curcumene, oleoresins [365].
Turmeric powder/ its alcoholic extract is not toxic at 10 g/kg
bw (LD50 > 15g/kg bw) in Swiss albino mice [366] or
Guinea pigs & monkeys (300mg/kg/ 2.5g/kg) [367].The
essential oil is safe when given orally up to 0.5 g/kg bw in
Wistar rats & is not mutagenic/genotoxic [368].
Cough [32], hernia, chest pain [23].
Sterols; diosgenin 3-glucoside;
phthalyl esters hydrocarbons [369].
No reports
Back pain [370], OI [23].
Anti-plasmodial,
steroids,
triterpenoids,
anthraquinolones, alkaloids & saponins [359].
No reports
Jo
ur
Zygophyllaceae
71. Balanites wilsoniana
Dawe & Sprague
Antiinflamatory
[353],
immunotoxicity in rats [354].
activity,
lP
Xanthorrhoeaceae
67. Aloe vera (L.) Burm.f.
Relevant
pharmacological
phytochemistry
na
Family & Scientific name
re
-p
ro
o
f
(500 mg/kg) of the ethanol leaf extract in male Swiss albino
mice [349].
Toxicity
yamogenin;
Malaria, skin infections, fever [23,33]
Key: OI = Opportunistic infection, STI = Sexually Transmitted Infection, p.o= per os, LD50 = Median lethal dose, bw=Body weight. All toxicity tests were acute
unless where otherwise
52